The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - Part I

Current Medicinal Chemistry

Volumn 19, Issue 14, 2012, Pages 2128-2175

  Schmidt, T J ^a   Khalid, S A ^b   Romanha, A J ^c,d   Alves, T M A ^d   Biavatti, M W ^c   Brun, R ^e   Da Costa, F B ^f   De Castro, S L ^d   Ferreira, V F ^g   De Lacerda, M V G ^h   Lago, J H G ⁱ   Leon, L L ^d   Lopes, N P ^f   Das Neves Amorim, R C ^j   Niehues, M ^f   Ogungbe, I V ^k   Pohlit, A M ^j   Scotti, M T ^l   Setzer, W N ^k   De Soeiro, M N C ^d   Steindel, M ^c   Tempone, A G ^m   more..

^a UNIVERSITY OF MÜNSTER   (Germany)

^b University of Science and Technology Omdurman   (Sudan)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e UNIVERSITY OF BASEL   (Switzerland)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^h FUNDAÇÃO DE MEDICINA TROPICAL DR HEITOR VIEIRA DOURADO   (Brazil)

ⁱ FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^j INSTITUTO NACIONAL DE PESQUISAS DA AMAZÔNIA   (Brazil)

^k UNIVERSITY OF ALABAMA IN HUNTSVILLE   (United States)

^l FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^m INSTITUTO ADOLFO LUTZ   (Brazil)

more..

Author keywords

Diterpene; Leishmania; Monoterpene; Natural product; Neglected tropical diseases; Plasmodium; Sesquiterpene; Triterpene; Trypanosoma

Indexed keywords

AGERATUM CONYZOIDES EXTRACT; AMPHOTERICIN B; ANTIPROTOZOAL AGENT; ARTEMISININ; BERGAPTEN; DITERPENE; EFLORNITHINE; EUDESMANOLIDE DERIVATIVE; FEXINIDAZOLE; GAMMA INTERFERON; GERMACRANOLIDE DERIVATIVE; LIMONOID; LUPEOL; MEGLUMINE ANTIMONATE; MELARSOPROL; MILTEFOSINE; MYRICETIN; NIFURTIMOX; PARTHENOLIDE; PENTAMIDINE; PENTAMIDINE ISETHIONATE; POSACONAZOLE; QUASSINOID; QUERCETIN; SCOPOLETIN; SCYX 7158; SESQUITERPENE LACTONE; STIBOGLUCONATE SODIUM; SURAMIN; TAFENOQUINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHYLETIN;

AFRICAN TRYPANOSOMIASIS; AGERATUM CONYZOIDES; ANAPHYLAXIS; ARTICLE; CHAGAS DISEASE; DIARRHEA; DRUG DETERMINATION; DRUG FATALITY; DRUG INDUSTRY; DRUG MEGADOSE; DRUG WITHDRAWAL; ENZYME ASSAY; FATIGUE; FEVER; HEADACHE; HUMAN; HYGIENE; HYPERTENSION; HYPOGLYCEMIA; INFECTION; LEISHMANIA; LEISHMANIASIS; MALARIA; MORTALITY; NAUSEA; NEPHROTOXICITY; NEUROLOGICAL COMPLICATION; NEUTROPENIA; NONHUMAN; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PLASMODIUM; PLASMODIUM FALCIPARUM; SEIZURE; SELF CARE; SEPTIC SHOCK; SHOCK; SOCIOECONOMICS; TANACETUM PARTHENIUM; TERATOGENICITY; TRYPANOSOMA; VOMITING; WORLD HEALTH ORGANIZATION;

EID: 84860676070     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712800229023     Document Type: Article

References (418)

1. Schmidt, T.J.; Khalid, S.A.; Romanha, A.J.; Alves, T.M.A.; Biavatti, M.W., Brun, R.; Da Costa, F.B.; de Castro, S.L.; Ferreira, V.F.; de Lacerda, M.V.G.; Lago, J.H.G.; Leon, L.L.; Lopes, N.P.; das Neves Amorim, R.C.; Niehues, M.; Ogungbe, I.V.; Pohlit, A.M.; Scotti, M.T., Setzer, W.N.; Soeiro, M. de N. C.; Steindel, M.; Tempone, A.G. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases -Part II. Curr. Med. Chem., 2012, this issue.
2. World Health Organization: First WHO report on neglected tropical diseases: Working to overcome the global impact of neglected tropical diseases, David WT. Crompton and Patricia Peters, Eds.; 2010, WHO Press, Geneva, Switzerland. ISBN 978 92 4 1564090. WHO/HTM/NTD/2010.1
3. World Health Organization: Working to overcome the global impact of neglected tropical diseases -update 2011. WHO/HTM/NTD/2011.3
4. Barrett, M. P.; Boykin, D.W.; Brun, R.; Tidwell, R.R. Human African trypanosomiasis: Pharmacological re-engagement with a neglected disease. Br. J. Pharmacol., 2007, 152, 1155-1171. (Pubitemid 350242432)
5. Kennedy, P.G. The continuing problem of human African trypanosomiasis (sleeping sickness). Ann. Neurol., 2008, 64, 116-126.
6. Stuart, K.; Brun, R.; Croft, S.; Fairlamb, A.; Gurtler, R. E.; McKerrow, J.; Reed, S.; Tarleton, R. Kinetoplastids: Related protozoan pathogens, different diseases. J. Clin. Invest., 2008, 118, 1301-1310. (Pubitemid 351500422)
7. Stockdale, C.; Swiderski, M. R.; Barry, J. D.; McCulloch, R. Antigenic variation in Trypanosoma brucei: Joining the DOTs. PLoS Biol., 2008, 6, e185.
8. Blum, J. A.; Zellweger, M. J.; Burri, C.; Hatz, C. Cardiac involvement in African and American trypanosomiasis. Lancet Infect. Dis., 2008, 8, 631-41.
9. Jacobs RT, Nare B and Phillips MA. State of the art in African trypanosome drug discovery. Current Topics in Med. Chem., 2011, 11, 1255-1274.
10. Blum, J. A.; Schmid, C.; Burri, C.; Hatz, C.; Olson, C.; Fungula, B.; Kazumba, L.; Mangoni, P.; Mbo, F.; Deo, K.; Mpanya, A.; Dala, A.; Franco, J. R.; Pohlig, G.; Zellweger, M. J. Cardiac alterations in human african trypanosomiasis (T.b. gambiense) with respect to the disease stage and antiparasitic treatment. PLoS Negl. Trop. Dis., 2009, 3, e383.
11. Astelbauer F., Walochnik J. Antiprotozoal compounds: State of the art and new developments. Int. J. Antimicr. Agents, 2011, 38, 118-124.
12. Robays, J.; Nyamowala, G.; Sese, C.; Betu Ku Mesu Kande, V.; Lutumba, P.; Van der Veken, W.; Boelaert, M. High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo. Emerg. Infect. Dis., 2008, 14, 966-967. (Pubitemid 351838613)
13. Maina, N.; Maina, K. J.; Maser, P.; Brun, R. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate. Acta Trop., 2007, 104, 84-90. (Pubitemid 47592836)
14. Balasegaram, M.; Young, H.; Chappuis, F.; Priotto, G.; Raguenaud, M. E.; Checchi, F. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Medecins Sans Frontieres programmes. Trans. R. Soc. Trop. Med. Hyg., 2009, 103, 280-290.
15. Sanderson, L.; Dogruel, M.; Rodgers, J.; Bradley, B.; Thomas, S. A. The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain. J.Neurochem., 2008, 107, 1136-1146.
16. Torreele, E.; Bourdin, T. B.; Tweats, D.; Kaiser, M.; Brun, R.; Mazué, G.; Bray, M.A.; Pécoul, B. Fexinidazole-a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness. PLoS Negl. Trop. Dis., 2010, 4, e923.
17. Nare, B.; Wring, S.; Bacchi, C.; Beaudet, B.; Bowling, T.; Brun, R.; Chen, D.; Ding, C.; Freund, Y.; Gaukel, E.; Hussain, A.; Jarnagin, K.; Jenks, M.; Kaiser, M.; Mercer, L.; Mejia, E.; Noe, A.; Orr, M.; Parham, R.; Plattner, J.; Randolph, R.; Rattendi, D.; Rewerts, C.; Sligar, J.; Yarlett, N.; Don, R.; Jacobs, R. Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system African trypanosomiasis. Antimicrob. Agents Chemother. 2010, 54, 4379-4388.
18. Ullu, E.; Tschudi, C.; Chakraborty, T. RNA interference in protozoan parasites. Cell Microbiol., 2004, 6, 509-519. (Pubitemid 38618662)
19. Herwaldt, B.L. Laboratory-acquired parasitic infections from accidental exposures. Clin. Microbiol. Rev., 2001, 14, 659-688. (Pubitemid 32979626)
20. Atclas, J.D.; Barcan, L.; Nagel, C.; Lattes, R.; Riarte, A. Organ transplantation and Chagas disease. JAMA, 2008, 299, 34-35.
21. Steindel, M.; Kramer Pacheco, L.; Scholl, D.; Soares, M.; Moraes, M.H.; Eger, I.; Kosmann, C.; Sincero, T.C.; Stoco, P.H.; Murta, S.M.; Carvalho-Pinto, C.J.; Grisard, E.C. Characterization of Trypanosoma cruzi isolated from humans, vectors, and animal reservoirs following an outbreak of acute human Chagas disease in Santa Catarina State, Brazil. Diagn. Microbiol. Inf. Dis., 2008, 60, 25-32. (Pubitemid 350235169)
22. Schmunis, G.A. Epidemiology of Chagas disease in non endemic countries: The role of international migration. Mem. Inst. Oswaldo Cruz, 2007, 102 suppl. 1, 75-85. (Pubitemid 350146006)
23. Dias, J.C.P.; Prata, A.; Correia, D. Problems and perspectives for Chagas disease control: In search of a realistic analysis. Rev. Soc. Bras. Med. Trop., 2008, 41, 193-196. (Pubitemid 351872401)
24. Abad-Franch F.; Santos W.S.; Schofield C.J. Research needs for Chagas disease prevention. Acta Trop., 2010, 115, 44-54.
25. Coura, J.R.; Borges-Pereira, J. Chagas disease: 100 years after its discovery. A systemic review. Acta Trop., 2010, 115, 5-13.
26. De Souza, W.; Carvalho, T.M.; Barrias, E.S. Review on Trypanosoma cruzi: Host cell interaction. Int. J. Cell Biol., 2010, Art. ID 295394.
27. Bilate, A.M.; Cunha-Neto, E. Chagas disease cardiomyopathy: Current concepts of an old disease. Rev. Inst. Med. Trop. São Paulo, 2008, 50, 67-74. (Pubitemid 351744065)
28. Rassi Jr. A.; Rassi A.; Marin-Neto J.A. Chagas disease. Lancet, 2010, 375, 1388-1402.
29. Junqueira, C.; Caetano, B.; Bartholomeu, D.C.; Melo, M.B.; Ropert, C.; Rodrigues, M.M.; Gazzinelli, R.T. The endless race between Trypanosoma cruzi and host immunity: Lessons for and beyond Chagas disease. Exp. Rev. Mol. Med., 2010, 12, e29.
30. Apt, W.; Arribada, A.; Zulantay, I.; Solari, A.; Sánchez, G.; Mundaca, K.; Coronado, X.; Rodríguez, J.; Gil, L.C.; Osuna, A. Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: The results of clinical and parasitological examinations 11 years post-treatment. Ann. Trop. Med. Parasitol., 2005, 99, 733-741. (Pubitemid 41695614)
31. Viotti, R.; Vigliano, C. Etiological treatment of chronic Chagas disease: Neglected 'evidence' by evidence-based medicine. Exp. Rev. Anti-Infective Ther., 2007, 5, 717-726. (Pubitemid 47250141)
32. Urbina, J.A. Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches. Acta Trop., 2010, 115, 55-68.
33. Marin-Neto, J.A.; Rassi Jr, A.; Avezum Jr, A.; Mattos, A.C.; Rassi, A.; Morillo, C.A.; Sosa-Estani, S.; Yusuf, S. The BENEFIT trial: Testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem. Inst. Oswaldo Cruz, 2009, 104, 319-324.
34. Romanha, A.J.; De Castro, S.L.; Soeiro, M.N.C.; Lannes-Vieira, J.; Ribeiro, I.; Talvani, A.; Bourdin, B.; Blum, B.; Olivieri, B.; Zani, C.; Spadafora, C.; Chiari, E.; Chatelain, E.; Chaves, G.; Calzada, J.E.; Bustamante, J.M.; Freitas Jr., L.; Romero, L.I.; Bahia, M.T.; Lotrowska, M.; Soares, M.; Andrade, S.G.; Armstrong, T.; Degrave, W.; Andrade, Z.A. In vitro and in vivo experimental models to drug screening and development for Chagas disease. Mem. Inst. Oswaldo Cruz, 2010, 105, 233-238.
35. Soeiro, M.N.C.; De Castro, S.L. Screening of potential anti-Trypanosoma candidates: In vitro and in vivo studies. Open Med. Chem. J., 2011, 5, 21-30.
36. Le Loup, G.; Pialoux, G.; Lescure, F.X. Update in treatment of Chagas disease. Curr. Opin. Infect. Dis., 2011, 24, 428-434.
37. Coura, J.R.; De Castro, S.L. A critical review on Chagas disease chemotherapy. Mem. Inst. Oswaldo Cruz, 2002, 97, 3-24. (Pubitemid 135746197)
38. Jannin, J.; Villa, L. An overview of Chagas disease treatment. Mem. Inst. Oswaldo Cruz, 2007, 102 (suppl. I), 95-95.
39. Rocha, M.O.; Teixeira, M.M.; Ribeiro, A.L. An update on the management of Chagas cardiomyopathy. Exp. Rev. Anti-Infective Ther., 2007, 5, 727-743. (Pubitemid 47250142)
40. Clayton J. Chagas disease: Pushing through the pipeline. Nature, 2010, 465, S12-5.
41. Brener, Z.; Cançado, J.R.; Galvão, L.M.; Da, Luz Z.M.; Filardi, L.S.; Pereira, M.E.; Santos, L.M.; Cançado, C.B. An experimental and clinical assay with ketoconazole in the treatment of Chagas disease. Mem. Inst. Instituto Oswaldo Cruz, 1993, 88, 149-153.
42. Solari, A.; Saavedra, H.; Sepulveda, C.; Oddó, D.; Acuña, G.; Labarca, J.; Muñoz, S.; Cuny, G.; Brengues, C.; Veas, F.; Bryan, R.T. Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS. Clin. Inf. Dis., 1993, 16, 255-259. (Pubitemid 23047425)
43. Pinazo, M.; Espinosa, G.; Gállego, M. Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus. Am. J. Trop. Med. Hyg., 2010, 82, 583-587.
44. Apt, W. Current and developing therapeutic agents in the treatment of Chagas disease. Drug Des. Develop. Ther., 2010, 4, 43-53.
45. Buckner, F.S.; Navabi, N. Advances in Chagas disease drug development: 2009-2010. Curr. Opin. Infect. Dis., 2010, 23, 609-616.
46. Soeiro, M.N.C.; De Castro, S.L. Trypanosoma cruzi targets for new chemotherapeutic approaches. Exp. Opin. Therap. Targ., 2009, 13, 105-121.
47. Moreira, D.R.; Leite, A.C.; Santos, R.R.; Soares, M.B. Approaches for the development of new anti-Trypanosoma cruzi agents. Curr. Drug Targets, 2009, 10, 212-231.
48. Rivera, G.; Bocanegra-García, V.; Ordaz-Pichardo, C.; Nogueda-Torres, B.; Monge, A. New therapeutic targets for drug design against Trypanosoma cruzi, advances and perspectives. Curr. Med. Chem., 2009, 16, 3286-3293.
49. Sánchez-Sancho, F.; Campillo, N.E.; Páez, J.A. Chagas disease: Progress and new perspectives. Curr. Med. Chem., 2010, 17, 423-452.
50. Desjeux, P. Leishmaniasis: Current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis., 2004, 27, 305-318. (Pubitemid 38842803)
51. WHO. Control of the Leishmaniases. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22-26 March 2010, WHO technical report series; no. 949, 2010, ISBN 978 92 4 120949 6.
52. Leon, L.L.; Machado, G.M.; Barral, A.; de Carvalho-Paes, L.E.; Grimaldi, G. Jr. Antigenic differences among Leishmania amazonensis isolates and their relationship with distinct clinical forms of the disease. Mem. Inst. Oswaldo Cruz, 1992, 87, 229-234.
53. Barral, A.; Pedral-Sampaio, D.; Grimaldi, G, Jr.; Momen, H.; McMahon-Pratt, D.; Ribeiro de Jesus, A.; Almeida, R.; Badaró, R.; Barral-Netto, M.; Carvalho, E. M.; Johnson, W. D. Jr. Leishmaniasis in Bahia, Brazil: Evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am. J. Trop. Med. Hyg., 1991, 44, 536-546.
54. Murray, H.W.; Berman, J.D.; Davies, C.R.; Saravia, N.G. Advances in leishmaniasis. Lancet, 2005, 366, 1561-1577. (Pubitemid 41540115)
55. Rijal, S.; Chappuis, F.; Singh, R.; Boelaert, M.; Loutan, L.; Koirala, S. Sodium stibogluconate cardiotoxicity and safety of generics. Trans. R. Soc. Trop. Med. Hyg., 2003, 97, 597-8. (Pubitemid 40590103)
56. Delgado, J.; Macías, J.; Pineda, J.A.; Corzo, J.E.; González-Moreno, M.P.; de la Rosa, R.; Sánchez-Quijano, A. ; Leal, M. ; Lissen, E. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients. Am. J. Trop. Med. Hyg., 1999, 61, 766-769.
57. Thakur, C.P.; Dedet, J.P.; Narain, S.; Pratlong, F.; Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India. Trans. R. Soc. Trop. Med. Hyg., 2001, 95,187-189. (Pubitemid 34947385)
58. Dey, S.; Papadopoulou, B.; Haimeur, A.; Roy, G.; Grondin, K.; Dou, D.; Rosen, B.P.; Ouellette, M. High level arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system. Mol. Biochem. Parasitol., 1994, 67, 49-57. (Pubitemid 24287310)
59. Shaked-Mishan, P.; Ulrich, N.; Ephros, M.; Zilberstein, D. Novel intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani. J. Biol. Chem., 2001, 276, 3971-3976.
60. Haimeur, A.; Ouellette, M. Gene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate. Antimicrob Agents Chemother 1998;42:1689-94. (Pubitemid 28311563)
61. Loiseau, P.M.; Mbongo, N.; Bories, C.; Boulard, Y.; Craciunescu, D.G. In vivo antileishmanial action of Ir-(COD)-pentamidine tetraphenylborate on Leishmania donovani and Leishmania major mouse models. Parasite, 2000, 7, 103-108.
62. Waalkes, T.P.; Makulu, D.R. Pharmacologic aspects of pentamidine. Natl. Cancer Inst. Monogr. 1976, 43, 171-177. (Pubitemid 8046835)
63. Brajtburg, J.; Bolard, J. Carrier effects on biological activity of amphotericin B. Clin. Microbiol. Rev. 1996, 9, 512-531. (Pubitemid 26366536)
64. Di Giorgio, C.; Faraut-Gambarelli, F.; Imbert, A.; Minodier, P.; Gasquet, M.; Dumon, H. Flow cytometric assessment of amphotericin B susceptibility in Leishmania infantum isolates from patients with visceral leishmaniasis. J. Antimicrob. Chemother., 1999, 44, 71-76. (Pubitemid 29353684)
65. AmBisome. Astellas Pharma US; 2010. http://www.ambisome.com/index2. php?section=about&page=overview [accessed Oct. 20, 2011].
66. Bern, C.; Adler-Moore, J.; Berenguer, J.; Boelaert, M.; den Boer, M.; Davidson, R.N.; Figueras, C.; Gradoni, L.; Kafetzis, D.A.; Ritmeijer, K.; Rosenthal, E.; Royce, C.; Russo, R.; Sundar, S.; Alvar, J. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin. Infect. Dis., 2006, 43, 917-924. (Pubitemid 44435523)
67. Sundar, S.; Jha, T.K.; Thakur, C.P.; Engel, J.; Sindermann, H.; Fischer, C., Junge, K.; Bryceson, A.; Berman, J. Oral miltefosine for Indian visceral leishmaniasis. N. Engl. J. Med. 2002, 347, 1739-1746. (Pubitemid 35375612)
68. Olliaro, P.L.; Guerin, P.J.; Gerstl, S.; Haaskjold, A.A.; Rottingen, J.A.; Sundar, S. Treatment options for visceral leishmaniasis: A systematic review of clinical studies done in India, 1980-2004. Lancet Infect. Dis., 2005, 5, 763-774. (Pubitemid 41688981)
69. Seifert, K.; Matu, S.; Perez-Victoria, F.J.; Castanys, S.; Gamarro, F.; Croft, S.L. Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). Int. J. Antimicrob. Agents, 2003, 22, 380-387. (Pubitemid 37163727)
70. Perez-Victoria, F.J.; Castanys, S.; Gamarro, F. Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug. Antimicrob. Agents Chemother., 2003, 47, 2397-2403. (Pubitemid 36919436)
71. Soto, J.; Soto, P. Miltefosine: Oral treatment of leishmaniasis. Expert Rev. Anti Infect. Ther., 2006, 4, 177-185.
72. El-On, J. Current status and perspectives of the immunotherapy of leishmaniasis. Isr. Med. Assoc. J., 2009, 11, 623-628.
73. Yardley, V.; Gamarro, F.; Croft, S.L. Antileishmanial and antitrypanosomal activities of the 8-aminoquinoline tafenoquine. Antimicrob. Agents Chemother., 2010, 54, 5356-5358.
74. Sen, R.; Ganguly, S.; Saha, P.; Chatterjee, M. Efficacy of artemisinin in experimental visceral leishmaniasis. Int. J. Antimicrob. Agents, 2010, 36, 43-49.
75. Barata, L.E.S.; Santos, L.S.; Ferri, P.H.; Phillipson, J.D.; Paine, A.; Croft, S.L. Anti-leishmanial activity of neolignans from Virola species and synthetic analogues. Phytochemistry, 2000, 55, 589-595.
76. Kaiser, O.; Kiderlen, A.F.; Laatsch, H.; Croft, S.L. In vitro leishmanicidal activity of monomeric and dimeric naphtoquinones. Acta Trop., 2000, 76, 131-138. (Pubitemid 30628859)
77. Costa, E.V.; Pinheiro, M. L.; Xavier, C. M.; Silva, J.R.; Amaral, A.C.; Souza, A.D.; Barison, A.; Campos, F.R.; Ferreira, A.G.; Machado, G.M.; Leon, L.L. A pyrimidine-beta-carboline and other alkaloids from Annona foetida with antileishmanial activity. J. Nat. Prod., 2006, 69, 292-294.
78. Berger, M.; Murugi, J.; Buch, E.; IJsselmuiden, C.; Moran, M.; Guzman, J.; Devlin, M.; Kubata, B. Strengthening pharmaceutical innovation in Africa. Council on Health Research for Development (COHRED); New Partnership for Africa's Development (NEPAD) 2010. Accessible at: Http://www.nepad.org/system/ files/str.pdf
79. Sá, J.M.; Chong, J.L.; Wellems, T.E. Malaria drug resistance: New observations and developments. Essays Biochem., 2011, 24,137-160.
80. Vitor-Silva, S.; Reyes-Lecca, R. C.; Pinheiro, T. R.; Lacerda, M. V. Malaria is associated with poor school performance in an endemic area of the Brazilian Amazon. Malar. J., 2009, 8, 230.
81. Alexandre, M. A.; Ferreira, C. O.; Siqueira, A. M.; Magalhaes, B. L.; Mourao, M. P. G.; Lacerda, M. V. G.; Alecrim, M. G. C. Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg. Infect. Dis., 2010, 16, 1611-1614.
82. Carlton, J. M.; Sina, B. J.; Adams, J. H. Why is Plasmodium vivax a neglected tropical disease? PLoS Negl. Trop. Dis., 2011, 5, e1160. doi:10.1371/journal.pntd.0001160.
83. Oliveira-Ferreira, J.; Lacerda, M. V.; Brasil, P.; Ladislau, J. L.; Tauil, P. L.; Daniel-Ribeiro, C. T. Malaria in Brazil: An overview. Malar. J., 2010, 9, 115.
84. Lacerda, M. V. G.; Zackiewicz, C.; Alecrim, W. D.; Alecrim, M. G. C. The neglected Plasmodium vivax: Are researchers from endemic areas really concerned about new treatment options? Rev. Soc. Bras. Med. Trop., 2007, 40, 489-490. (Pubitemid 47395254)
85. The RTS, S Clinical Trials Partnership. First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children. N. Engl. J. Med., 2011, 365, 1863-1875.
86. Mueller, I.; Galinski, M. R.; Baird, J. K.; Carlton, J. M.; Kochar, D.K.; Alonso, P. L.; Portillo, H. A. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect. Dis., 2009, 9, 555-566.
87. The malERA Consultative Group on Basic Science and Enabling Technologies. A Research Agenda for Malaria Eradication: Basic Science and Enabling Technologies. PLoS Med., 2011, 8, e1000399. doi:10.1371/journal.pmed.1000399
88. Rieckmann, K. H.; Davis, D. R.; Hutton, D. C. Plasmodium vivax resistance to chloroquine? Lancet, 1989, 334, 1183-1184. (Pubitemid 19275451)
89. Sumawinata, I. W.; Bernadeta, M.; Leksana, B.; Sutamihardja, A.; Purnomo, J.; Subianto, B.; Sekartuti; Fryauff, D. J.; Baird, J. K. Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. Am. J. Trop. Med. Hyg., 2003, 68, 416-420. (Pubitemid 38230641)
90. Alecrim, M.G.C.; Alecrim, W.; Macêdo, V. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region. Rev. Soc. Bras. Med. Trop., 1999, 32, 67-68. (Pubitemid 29006271)
91. Santana Filho, F. S.; Arcanjo, A. R.; Chehuan, Y. M.; Costa, M. R.; Martinez-Espinosa, F. E.; Vieira, J. L.; Barbosa, M. G.; Alecrim, W. D.; Alecrim, M. G. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg. Infect. Dis., 2007, 13, 1125-1126. (Pubitemid 47048104)
92. Gama, B. E.; Lacerda, M. V.; Daniel-Ribeiro, C. T.; Ferreira-da-Cruz, M. F. Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: Consequences on disease morbidity and control. Mem. Inst. Oswaldo Cruz, 2011, 106, Suppl. 1, 159-166.
93. Ramos Junior, W. M.; Sardinha, J. F.; Costa, M. R.; Santana, M. S.; Alecrim, M. G.; Lacerda, M. V. Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon. Braz. J. Infect. Dis., 2010, 14, 410-412.
94. NIAID Malaria Working Group, National Institute of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID). Research Agenda for Malaria. April, 2008. http://www.niaid.nih.gov/topics/Malaria/Documents/ researchagenda.pdf (Accessed Oct. 30, 2011).
95. Roll Back Malaria. Global Malaria Action Plan. http://www.rbm. who.int/gmap/ (Accessed Oct. 30, 2011).
96. Newman, D.J.; Cragg, G.M. Natural Products as Sources of New Drugs over the Last 25 Years. J. Nat. Prod., 2007, 70, 461-477. (Pubitemid 46595760)
97. Firn, R.D.; Jones, C.G. Natural products -a simple model to explain chemical diversity. Nat. Prod. Rep., 2003, 20, 382-391. (Pubitemid 37007962)
98. Quinn, R.J.; Carroll, A.R.; Pham, N.B.; Baron, P.; Palframan, M.E.; Suraweera, L.; Pierens, G.K.; Muresan, S. Developing a Drug-like Natural Product Library. J. Nat. Prod., 2008, 71, 464-468. (Pubitemid 351549376)
99. Ertl, P.; Roggo, S.; Schuffenhauer, A. Natural Product-likeness Score and Its Application for Prioritization of Compound Libraries. J. Chem. Inf. Model., 2008, 48, 68-74. (Pubitemid 351271051)
100. Schmidt, T.J. In: Studies in Natural Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier Science B.V: Amsterdam, 2006; Vol. 33, pp. 309-392.
101. Stanton, D.T. Evaluation and use of BCUT descriptors in QSAR and QSPR studies. J. Chem. Inf. Comput. Sci., 1999, 39, 11-20. (Pubitemid 129676552)
102. Cavallaro, C.L.; Schnur, D.M.; Tebben, A.J. Molecular Diversity in Lead Discovery: From Quantity to Quality. In: Chemoinformatics in Drug Discovery; Oprea T., Ed.; Wiley VCH: Weinheim, 2005; pp. 175-198.
103. Varmuza, K. Multivariate Data Analysis in Chemistry. In: Handbook of Chemoinformatics; Gasteiger, J., Ed.; Wiley VCH: Weinheim, 2003; Vol. 3, pp. 1098-1133.
104. MDL Available Chemicals Database (ACD), accessed Dec. 2006; available at www.mdl.com
105. MDL Drug Data Report (MDDR), accessed Dec. 2006; available at www.mdl.com
106. Buckingham, J.; Hodgson, A.M.; Walford, S. P.; Eds.; The Dictionary of Natural Products on CDROM, v. 10:2; Chapman & Hall/CRC: Boca Raton, 2002.
107. Cordell, G. Biodiversity and drug discovery-a symbiotic relationship. Phytochemistry , 2000, 55, 463-480.
108. Lahlou, M. Screening of natural products for drug discovery. Expert Opin. Drug Discov. 2007, 2, 697-705. (Pubitemid 47064963)
109. Nour, A.M.M.; Khalid, S.A.; Kaiser, M.; Brun, R.; Abdallah, W.E.; Schmidt, T.J. The antiprotozoal activity of sixteen asteraceae species native to Sudan and bioactivity-guided isolation of xanthanolides from Xanthium brasilicum. Planta Med., 2009, 75, 1363-1368.
110. Koehn, F.E. In:Natural Compounds as Drugs. Birkhaeuser Verlag Ed. Basel, 2008; Vol 1, pp. 175-210.
111. Wolfender, J.L.; Marti, G.; Queiroz, E.F. Advances in Techniques for Profiling Crude Extracts and for the Rapid Identification of Natural Products: Dereplication, Quality Control and Metabolomics. Current Organic Chemistry, 2010, 14, 1808-1832.
112. Queiroz, E.F.; Wolfender, J.L.; Hostettmann, K. Modern Approaches in the Search for New Lead Antiparasitic Compounds from Higher Plants. Current Drug Targets, 2009, 72, 202-211s
113. McCloud, T.G. High Throughput Extraction of Plant, Marine and Fungal Specimens for Preservation of Biologically Active Molecules. Molecules 2010, 15, 4526-4563.
114. Scio, E.; Ribeiro, A.; Alves, T.M.A.; Romanha, A.J.; Souza-Filho, J.D.; Cordell, G.A.; Zani, C.L. Diterpenes from Alomia myriadenia (Asteraceae) with cytotoxic and trypanocidal activity. Phytochemistry, 2003, 64, 1125-1131. (Pubitemid 37295335)
115. Scio, E.; Ribeiro, A.; Alves, T.M.A.; Romanha, A.J.; Shin, Y.G.; Cordell, G.A.; Zani, C.L. New Bioactive Coumarins from Kielmeyera albopunctata. J. Nat. Prod., 2003, 66, 634-637. (Pubitemid 36617886)
116. Choi, Y.; Jermihov, K.; Nam, S.J.; Sturdy, M.; Maloney, K.; Qiu, X.; Chadwick, L.R.; Main, M.; Chen, S.N; Mesecar, A.D.; Farnsworth, N.R.; Pauli, G.F.; Fenical, W.; Pezzuto, J.M.; van Breemen, R. Screening Natural Products for Inhibitors of Quinone Reductase-2 Using Ultrafiltration LC-MS. Anal. Chem.. 2011, 83, 1048-1052.
117. Julianti, T.; Hata, Y., Zimmermann, S.; Kaiser, M.; Hamburger, M.; Adams, M. Antitrypanosomal sesquiterpene lactones from Saussurea costus. Fitoterapia, 2011, 82, 955-959.
118. Yeh, I.; Hanekamp, T.; Tsoka, S.; Karp, P.D.; Altman, R.B. Computational analysis of Plasmodium falciparum metabolism: Organizing genomic information to facilitate drug discovery. Genome Res., 2004, 14, 917-924. (Pubitemid 38660510)
119. Chavali, A.K.; Whittemore, J.D.; Eddy, J.A.; Williams, K.T.; Papin, J.A. Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major. Mol. Syst. Biol., 2008, 4, 177. (Pubitemid 351441044)
120. Alves-Ferreira, M.; Guimarães, A.C.R.; Capriles, P.V.d.S.Z.; Dardenne, L.E.; Degrave, W.M. A new approach for potential drug target discovery through in silico metabolic pathway analysis using Trypanosoma cruzi genome information. Mem. Inst. Oswaldo Cruz, 2009, 104, 1100-1110.
121. Crowther, G.J.; Shanmugam, D.; Carmona, S.J.; Doyle, M.A.; Hertz-Fowler, C.; Berriman, M.; Nwaka, S.; Ralph, S.A.; Roos, D.S.; Van Voorhis, W.C.; Agüero, F. Identification of attractive drug targets in neglected disease pathogens using an in silico approach. PLoS Negl. Trop. Dis., 2010, 4, e804.
122. Duncan, R.; Gannavaram, S.; Dey, R.; Debrabant, A.; Lakhal-Naouar, I.; Nakhasi, H.L. Identification and characterization of genes involved in Leishmania pathogenesis: The potential for drug target selection. Mol. Biol. Int., 2011, ID-428486.
123. Souza, D.H.F.; Garratt, R.C.; Araújo, A.P.U.; Guimarães, B.G.; Jesus, W.D.P.; Michels, P.A.M.; Hannaert, V.; Oliva, G. Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase: Structure, catalytic mechanism and targeted inhibitor design. FEBS Lett., 1998, 424, 131-135. (Pubitemid 28135298)
124. Tomazela, D.M.; Pupo, M.T.; Passador, E.A.P.; Silva, M.F.G.F.; Vieira, P.C.; Fernandes, J.B.; Fo, E.R.; Oliva, G.; Pirani, J.R. Pyrano chalcones and a flavone from Neoraputia magnifica and their Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase-inhibitory activities. Phytochemistry, 2000, 55, 643-651.
125. Vieira, P.C.; Mafezoli, J.; Pupo, M.T.; Fernandes, J.B.; Silva, M.F.G.F.; Albuquerque, S.; Oliva, G.; Pavão, F. Strategies for the isolation and identification of trypanocidal compounds from the Rutales. Pure Appl. Chem., 2001, 73, 617-622.
126. Pavão, F.; Castilho, M.S.; Pupo, M.T.; Dias, R.L.A.; Correa, A.G.; Fernandes, J.B.; Silva, M.F.G.F.; Mafezoli, J.; Vieira, P.C.; Oliva, G. Structure of Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase complexed with chalepin, a natural product inhibitor, at 1.95 A resolution. FEBS Lett., 2002, 520, 13-17. (Pubitemid 34607265)
127. Nyasse, B.; Gnantchou, I.; Tchana, E.M.; Sonké, B.; Denier, C.; Fontaine, C. Inhibition of both Trypanosoma brucei bloodstream form and related glycolytic enzymes by a new kolavic acid derivative isolated from Entada abyssinica. Pharmazie, 2004, 59, 873-875. (Pubitemid 39524587)
128. Ngantchou, I.; Nyasse, B.; Denier, C.; Blonski, C.; Hannaert, V.; Schneider, B. Antitrypanosomal alkaloids from Polyalthia suaveolens (Annonaceae): Their effects on three selected glycolytic enzymes of Trypanosoma brucei. Bioorg. Med. Chem. Lett., 2010, 20, 3495-3498.
129. Sajid, M.; Robertson, S.A.; Brinen, L.S.; McKerrow, J.H. Cruzain -The path from target validation to the clinic. In: Cysteine Proteases of Pathogenic Organisms, Robinson, M.W.; Dalton, J.P., Eds.; Springer: New York, 2011; Chapter 7.
130. Setzer, W.N.; Stokes, S.L.; Bansal, A.; Haber, W.A.; Caffrey, C.R.; Hansell, E.; McKerrow, J.H. Chemical composition and cruzain inhibitory activity of Croton draco bark essential oil from Monteverde, Costa Rica. Nat. Prod. Commun., 2007, 2, 685-689.
131. Stokes, S.L.; Cole, R.A.; Rangelova, M.P.; Haber, W.A.; Setzer, W.N. Cruzain inhibitory activity of the leaf essential oil from an undescribed species of Eugenia from Monteverde, Costa Rica. Nat. Prod. Commun., 2007, 2, 1211-1213.
132. Setzer, W.N.; Stokes, S.L.; Penton, A.F.; Takaku, S.; Haber, W.A.; Hansell, E.; Caffrey, C.R.; McKerrow, J.H. Cruzain inhibitory activity of leaf essential oils of Neotropical Lauraceae and essential oil components. Nat. Prod. Commun., 2007, 2, 1203-1210.
133. Setzer, W.N.; Takaku, S.; Stokes, S.L.; Penton, A.F. Inhibition of cruzain by Ocotea leaf essential oils from Monteverde, Costa Rica. Pharmacologyonline, 2006, 3, 785-793.
134. Richter, L.R.; Vogler, B.; Penton, A.F.; Setzer, W.N.; Haber, W.A.; Caffrey, C.R.; Hansell, E.; McKerrow, J.H. 3-O-(3'-Hydroxytetradecanoyl)lupeol from Sorocea trophoides inhibits cruzain. Nat. Prod. Commun., 2007, 2, 887-888.
135. Agius, B.R.; Vogler, B.; Stokes, S.L.; Setzer, W.N.; Caffrey, C.R.; Hansell, E.; McKerrow, J.H. Inhibition of cruzain by triterpenoids isolated from a Salacia species from Monteverde, Costa Rica. Nat. Prod. Commun., 2007, 2, 1083-1084.
136. Kerr, I.D.; Wu, P.; Marion-Tsukamaki, R.; Mackey, Z.B.; Brinen, L.S. Crystal structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei. PLoS Negl. Trop. Dis., 2010, 4, e701.
137. Ogungbe, I.V.; Crouch, R.A.; Haber, W.A.; Setzer, W.N. Phytochemical investigation of Verbesina turbacensis Kunth: Trypanosome cysteine protease inhibition by (-)-bornyl esters. Nat. Prod. Commun., 2010, 5, 1161-1166.
138. Ogungbe. I.V.; Hill, G.M.; Crouch, R.A.; Vogler, B.; Nagarkoti, M.; Haber, W.A.; Setzer, W.N. Prenylated isoflavonoids from Rhynchosia edulis. Nat. Prod. Commun., 2011, 6, in press.
139. Waag, T.; Gelhaus, C.; Rath, J.; Stich, A.; Leippe, M.; Shirmeister, T. Allicin and derivates are cysteine protease inhibitors with antiparasitic activity. Bioorg. Med. Chem. Lett., 2010, 20, 5541-5543.
140. Krieger, S.; Schwarz, W.; Ariyanayagam, M.R.; Fairlamb, A.H.; Krauth-Siegel, R.L.; Clayton, C. Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress. Mol. Microbiol., 2000, 35, 542-552. (Pubitemid 30085272)
141. Gallwitz, H.; Bonse, S.; Martinez-Cruz, A.; Schlichting, I.; Schumacher, K.; Krauth-Siegel, R.L. Ajoene is an inhibitor and subversive substrate of human glutathione reductase and Trypanosoma cruzi trypanothione reductase: Crystallographic, kinetic, and spectroscopic studies. J. Med. Chem., 1999, 42, 364-372. (Pubitemid 29085096)
142. Bond, C.S.; Zhang, Y.; Berriman, M.; Cunningham, M.L.; Fairlamb, A.H.; Hunter, W.N. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors. Structure, 1999, 7, 81-89. (Pubitemid 29159184)
143. Gayosso-De-Lucio, J.; Torres-Valencia, M.; Rojo-Domínguez, A.; Nájera-Peña, H.; Aguirre-López, B.; Salas-Pacheco, J.; Avitia-Domínguez, C.; Téllez-Valencia, A. Selective inactivation of triosephosphate isomerase from Trypanosoma cruzi by brevifolin carboxylate derivatives isolated from Geranium bellum Rose. Bioorg. Med. Chem. Lett., 2009, 19, 5936-5939.
144. Dodson, H.C.; Lyda, T.A.; Chambers, J.W.; Morris, M.T.; Christensen, K.A.; Morris, J.C. Quercetin, a fluorescent bioflavonoid, inhibits Trypanosoma brucei hexokinase 1. Expt. Parasitol., 2011, 127, 423-428.
145. Baltz, T.; Baltz, D.; Giroud, C.; Crockett, J. Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense. EMBO J., 1985, 4, 1273-1277.
146. Hirumi, H.; Hirumi, K. Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers. J. Parasitol., 1989, 75, 985-989. (Pubitemid 20099178)
147. Otoguro, K.; Iwatsuki, M.; Ishiyama, A.; Namatame, M.; Nishihara-Tukashima, A.; Kiyohara, H.; Hashimoto, T.; Asakawa, Y.; Omura, S.; Yamada, H. In vitro antitrypanosomal activity of plant terpenes against Trypanosoma brucei. Phytochemistry, 2011, 72, 2024-2030.
148. Räz, B.; Iten, M.; Grether-Bühler, Y.; Kaminsky, R.; Brun, R. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. Acta Trop., 1997, 68, 139-147. (Pubitemid 27438330)
149. Orhan, I.; Sener, B.; Kaiser, M.; Brun, R.; Tasdemir, D. Inhibitory activity of marine sponge-derived natural products against parasitic protozoa. Mar. Drugs, 2010, 8, 47-58.
150. Brun, R.; Blum, J.; Chappuis, F.; Burri, C. Human African trypanosomiasis. Lancet, 2010, 375, 148-159.
151. Brun, R.; Schumacher, R.; Schmid, C.; Kunz, C.; Burri, C. The phenomenon of treatment failures in Human African Trypanosomiasis. Trop. Med. Int. Health, 2001, 6, 906-914. (Pubitemid 33010877)
152. Bernhard, S.C.; Nerima, B.; Mäser, P.; Brun, R. Melarsoprol-and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance. Int. J. Parasitol., 2007, 37, 1443-1448. (Pubitemid 47417979)
153. Matovu, E.; Stewart, M.L.; Geiser, F.; Brun, R.; Mäser, P.; Wallace, L.J.; Burchmore, R.J.; Enyaru, J.C.; Barrett, M.P.; Kaminsky, R.; Seebeck, T.; de Koning, H.P. Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei. Eukaryot. Cell, 2003, 2, 1003-1008. (Pubitemid 37298713)
154. Buckner, F.S.; Verlinde, C.L.; La Flamme, A.C.; Van Voorhis, W.C. Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase. Antimicrob. Agents Chemother., 1996, 40, 2592-2597. (Pubitemid 26367650)
155. Bettiol, E.; Samanovic, M.; Murkin, A.S.; Raper, J.; Buckner, F.; Rodriguez, A. Identification of three classes of heteroaromatic compounds with activity against intracellular Trypanosoma cruzi by chemical library screening. PLoS Negl. Trop. Dis., 2009, 3, e384.
156. Nwaka, S.; Hudson, A. Innovative lead discovery strategies for tropical diseases. Nat. Rev. Drug Discov., 2006, 5, 941-955. (Pubitemid 44660607)
157. Andrade, S.G.; Magalhães, J.B.; Pontes, A.L. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types. Bull. World Health Org., 1985, 63, 721-726. (Pubitemid 16214155)
158. Filardi L.S.; Brener, Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans. Royal Soc. Trop. Med. Hyg., 1987, 81, 755-759. (Pubitemid 18070985)
159. McKerrow, J.H.; Doyle, P.S.; Engel, J.C.; Podust, L.M.; Robertson, S.A.; Ferreira, R.; Saxton, T.; Arkin, M.; Kerr, I.D.; Brinen, L.S.; Craik, C.S. Two approaches to discovering and developing new drugs for Chagas disease. Mem. Inst. Oswaldo Cruz, 2009, 104 (Suppl 1), 263-269.
160. Zingales, B.; Andrade, S.G.; Briones, M.R.S.; Campbell, D.A.; Chiari, E.; Fernandes, O.; Guhl, F.; Lages-Silva, E.; Macedo, A.M.; Machado, C.R.; Miles, M.A.; Romanha, A.J.; Sturm, N.R.; Tibayrenc, M.; Schijman, A.G. Recommendations from the second satellite meeting for the revision and standardization of the nomenclature of Trypanosoma cruzi strains. Mem. Inst. Oswaldo Cruz, 2009, 104, 1051-1054.
161. Tempone, A.G.; Martins de Oliveira, C.; Berlinck, R.G. Current approaches to discover marine antileishmanial natural products. Planta Med., 2011, 77, 572-85.
162. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Meth., 1983, 65, 55-63. (Pubitemid 14203433)
163. Mikus, J.; Steverding, D. A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar blue. Parasitol. Int., 2000, 48, 265-269.
164. Garner, D.L.; Johnson, L.A.; Yue, S.T.; Roth, B.L.; Haugland, R.P. Dual DNA staining assessment of bovine sperm viability using SYBR-14 and propidium iodide. J. Androl., 1994, 15, 620-629.
165. Messaritakis, I.; Mazeris, A.; Koutala, E.; Antoniou, M. Leishmania donovani s.l: Evaluation of the proliferation potential of promastigotes using CFSE stainin and flow cytometry. Exp. Parasitol., 2010, 125, 384-388.
166. Callahan, H.L.; Portal, A.C.; Devereaux, R.; Grögl, M. An axenic amastigote system for drug screening. Antimicrob. Agents Chemother., 1997, 41, 818-822. (Pubitemid 27150538)
167. Ephros, M.; Waldman, E.; Zilberstein, D. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes. Antimicrob. Agents Chemother., 1997, 41, 1064-1068. (Pubitemid 27194186)
168. Sereno, D.; Alegre, A.M.; Silvestre, R.; Vergnes, B.; Ouaissi, A. In vitro antileishmanial activity of nicotinamide. Antimicrob. Agents Chemother., 2005, 49, 808-812. (Pubitemid 40175704)
169. Vergnes, B.; Vanhille, L.; Ouaissi, A.; Sereno, D. Stage-specific & antileishmanial activity of an inhibitor of SIR2 histone deacetylase. Acta Trop., 2005, 94, 107-115. (Pubitemid 40693094)
170. Gupta, S.; Nishi. Visceral leishmaniasis: Experimental models for drug discovery. Indian J. Med. Res., 2011, 133, 27-39.
171. Sereno, D.; Cordeiro da Silva, A.; Mathieu-Daude, F.; Ouaissi, A. Advances and perspectives in Leishmania cell based drug-screening procedures. Parasitol. Int., 2007, 56, 3-7.
172. Naylor, L.H. Reporter gene technology: The future look bright. Biochem. Pharmacol., 1999, 58, 749-757. (Pubitemid 29329523)
173. Lang, T.; Goyard, S.; Lebastard, M.; Milon, G. Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice. Cell Microbiol., 2005, 7, 383-392. (Pubitemid 40277918)
174. Tsien, R.Y. Green fluorescent protein. Annu. Rev. Biochem., 1998, 67, 509-544.
175. Okuno, T.; Goto, Y.; Matsumoto, Y.; Otsuka, H.; Matsumoto, Y. Applications of recombinant Leishmania amazonensis expressing egfp or the beta galactosidase gene for drug screening and histopathological analysis. Exp. Anim., 2003, 52, 109-118. (Pubitemid 41349974)
176. Osorio, Y.; Travi, B.L.; Renslo, A.R.; Peniche, A.G.; Melby, P.C. Identification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model system. PLoS Negl. Trop. Dis., 2011, 5, e962.
177. Trager, W.; Jensen, J.B. Human malaria parasites in continuous culture. Science, 1976, 193, 673-675.
178. Lambros, C.; Vanderberg, J. P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol., 1979, 65, 418-420. (Pubitemid 10222999)
179. WHO/World Health Organization. In vitro micro-test (Mark III) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, amodiaquine, sulfadoxine / pyrimetamine and artemisinin. Division of Control of Tropical Disease. Rev. 2 CTD/MAL/97.20, 2001.
180. Suwanarusk R.; Russell B.; Chavchich M.; Chalfein F.; Kenangalem E.; Kosaisavee V.; Prasetyorini B.; Piera K.A.; Barends M.; Brockman A.; Lek-Uthai, U.; Anstey, N.M.; Tjitra, E.; Nosten,F.; Cheng, Q.; Price, R.N. Chloroquine resistant Plasmodium vivax: In vitro characterisation and association with molecular polymorphisms. PLoS ONE, 2007, 2, e1089.
181. Druilhe, P.; Brasseur, P.; Blanc, C.; Makler, M. Improved assessment of Plasmodium vivax response to antimalarial drugs by a colorimetric doublesite Plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay. Antimicrob. Agents Chemother., 2007, 51, 2112-2116. (Pubitemid 46903102)
182. Russell B.; Suwanarusk R.; Borlon C.; Costa F.T.; Chu C.S.; Rijken M.J.; Sriprawat K.; Warter L.; Koh E.G.; Malleret B.; Colin, Y.; Bertrand, O.; Adams, J.H.; D'Alessandro, U.; Snounou, G.; Nosten, F.; Rénia, L. A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax. Blood, 2011, 118, e74-81.
183. Andrade-Neto V.F.; Brandao M.G.; Nogueira F.; Rosario V.E.; Krettli A.U. Ampelozyziphus amazonicus Ducke (Rhamnaceae), a medicinal plant used to prevent malaria in the Amazon Region, hampers the development of Plasmodium berghei sporozoites. Int. J. Parasitol., 2008, 38,1505-1511.
184. Brun, R.; Kaminsky, R. Animal models of acute (1st stage) sleeping sickness. In: Animal Models for Antimicrobial Chemotherapy: Parasitic Infection; Zak, O.; Sande, M., Eds.; Academic Press: London, 1999.
185. Gichuki, C.; Brun, R. Animal models of CNS (2nd stage) sleeping sickness. In: Animal Models for Antimicrobial Chemotherapy: Parasitic Infection; Zak, O.; Sande, M., Eds.; Academic Press: London, 1999.
186. Inoue, N.; Narumi, D.; Mbati, P.A.; Hirumi, K.; Situakibanza, N.T.; Hirumi, H. Susceptibility of severe combined immuno-deficient (SCID) mice to Trypanosoma brucei gambiense and T. b. rhodesiense. Trop. Med. Int. Health, 1998, 3, 408-412. (Pubitemid 28232303)
187. Maina, N.W.; Oberle, M.; Otieno, C.; Kunz, C.; Maeser, P.; Ndung'u, J.M.; Brun, R. Isolation and propagation of Trypanosoma brucei gambiense from sleeping sickness patients in south Sudan. Trans. R. Soc. Trop. Med. Hyg., 2007, 101, 540-546. (Pubitemid 46613461)
188. Jennings, F.W.; Whitelaw, D.D.; Urquhart, G.M. The relationship between duration of infection with Trypanosoma brucei in mice and the efficacy of chemotherapy. Parasitology, 1977, 75, 143-153. (Pubitemid 8240436)
189. Walum, E. Acute oral toxicity. Environm. Health Persp., 1998, 106, 497-503. (Pubitemid 28256758)
190. Brener, Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev. Inst. Med. Trop. São Paulo, 1962, 4, 386-396.
191. Britto, C.; Cardoso, M.A.; Wincker, P.; Morel, C.M. A simple protocol for the physical cleavage of Trypanosoma cruzi kinetoplast DNA present in blood samples and its use in polymerase chain reaction (PCR)-based diagnosis of chronic Chagas disease. Mem. Inst. Oswaldo Cruz, 1993, 88, 171-172.
192. Batista, D.G.; Batista, M.M.; Oliveira, G.M.; Amaral, P.B.; Lannes-Vieira, J.; Britto, C.C.; Junqueira, A.; Lima, M.M.; Romanha, A.J.; Sales Junior, P.A.; Stephens, C.E.; Boykin, D.W.; Soeiro, M.N.C. Arylimidamide DB766: A potential chemotherapeutic candidate for Chagas disease treatment. Antimicrob. Agents Chemother., 2010, 54, 2940-2952.
193. Batista, D.G.; Silva, P.B.; Stivanin, L.; Lachter, D.R.; Silva, R.S.; Felcman, J.; Louro, S.R.W.; Teixeira, L.R.; Soeiro, M.N.C. Co(II), Mn(II) and Cu(II) complexes of fluoroquinolones: Synthesis, spectroscopical studies and biological evaluation against Trypanosoma cruzi. Polyhedron, 2011, 10, 1718-1725.
194. Bustamante, J.M.; Bixby, L.M.; Tarleton, R.L. Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nature Medicine, 2008, 14, 542-550. (Pubitemid 351655210)
195. Santos, F.M.; Caldas, S.; Assis Cáu, S.B.; Crepalde, G.P.; de Lana, M.; Machado-Coelho, G.L.; Veloso, V.M.; Bahia, M.T. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection. Exp. Parasitol., 2008, 120, 385-390.
196. Sakthianandeswaren, A.; Foote, S.J.; Handman, E. The role of host genetics in leishmaniasis. Trends Parasitol., 2009, 25, 383-391.
197. Cangussú, S.D.; Souza, C.C.; Campos, C.F.; Vieira, L.Q.; Afonso, L.C.; Arantes, R.M. Histopathology of Leishmania major infection: Revisiting L. major histopathology in the ear dermis infection model. Mem. Inst. Oswaldo Cruz, 2009, 104, 918-922.
198. Charret, K.; Rodrigues, R.; Bernardino, A.M.R.; Gomes, A.; Carvalho, A.; Cavalheiro, M.M.C.; Leon, L.L.; Amaral, V.A.C. Effect of oral treatment with pyrazole carbohydrazide derivatives against murine infection by Leishmania amazonensis. Am. J. Trop. Med. Hyg., 2009, 80, 568-573.
199. Rodrigues, R.; Charret, K.S.; Silva, E.; Echevarria, A.; Amaral, V.A.C.; Leon, L.L.; Cavalheiro, M.M.C. Antileishmanial activity of 1,3,4-thiadiazolium- 2-aminide in mice infected with Leishmania amazonensis. Antimicrob. Agents Chemother., 2009, 17, 839-842.
200. Reiner, S.L.; Loksley, R.M. The regulation of immunity of Leishmania major. Ann. Rev. Immunol., 1995, 13, 151-177.
201. Scott, P. The role of TH1 and TH2 cells in experimental cutaneous leishmaniasis. Exp. Parasitol., 1989, 68, 369-372.
202. Croft, S.L.; Yardley, V. In: Handbooks of animals models of infection; Zac, O.; Sande, M. Eds; Academic Press, Waltham, USA, 1999; Chapter. 94, pp. 783-787.
203. Croft, S.L.; Seifert, K.; Yardley, V. Current scenario of drug development for leishmaniasis. Indian J. Med. Res., 2006, 123, 399-410. (Pubitemid 43905578)
204. Joshi, T.; Rodriguez, S.; Perovic, V.; Cockburn, I.A.; Stäger, S. B7-H1 Blockade increases survival of dysfunctional CD8+ T cells and confers protection against Leishmania donovani infections. PLoS Pathog., 2009, e1000431.
205. Garg, R.; Dube, A. Animal models for vaccine studies for visceral leishmaniasis. Indian. J. Med. Res., 2006, 123, 439-454. (Pubitemid 43905581)
206. Seifert, K.; Croft, S.L. In vitro and in vivo interactions between miltefosine and other antileishmanial drugs. Antimicrob. Agents Chemother., 2006, 50, 73-79. (Pubitemid 43042905)
207. Grogl, M.; Thomason, T.N.; Franke, E.D. Drug resistance in leishmaniasis: Its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am. J. Trop. Med. Hyg., 1992, 47, 117-126.
208. Garnier, T.; Mäntylä, A.; Järvinen, T.; Lawrence, J.; Brown, M.; Croft, S.L. In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs. J. Antimicrob. Chemother., 2007, 60, 802-810. (Pubitemid 47434259)
209. Wang, M.Z.; Zhu, X.; Srivastava, A.; Liu, Q.; Sweat, J.M.; Pandharkar, T.; Stephens, C.E.; Riccio, E.; Parman, T.; Munde, M.; Mandal, S.; Madhubala, R.; Tidwell, R.R.; Wilson, W.D.; Boykin, D.W.; Hall, J.E.; Kyle, D.E.; Werbovetz, K.A. Novel arylimidamides for treatment of visceral leishmaniasis. Antimicrob. Agents Chemother., 2010, 54, 2507-2516.
210. Cupolilo, S.M.; Souza, C.S.; Abreu-Silva, A.L.; Calabrese, K.S.; Goncalves da Costa, S.C. Biological behavior of Leishmania (L.) amazonensis isolated from a human diffuse cutaneous leishmaniasis in inbred strains of mice. Histol. Histopathol. 2003, 18, 1059-1065. (Pubitemid 37265009)
211. de Oliveira Cardoso, F.; de Souza, C.S.; Mendes, V.G.; Abreu-Silva, A.L.; Gonçalves da Costa, S.C.; Calabrese, K.S. Immunopathological studies of Leishmania amazonensis infection in resistant and in susceptible mice. J. Infect. Dis., 2010, 201, 1933-1940.
212. Bradley, D.J.; Kirkley, J. Regulation of Leishmania populations within the host.I. The variable course of Leishmania donovani infections in mice. Clin. Exp. Immunol., 1977, 30, 119-129. (Pubitemid 8249312)
213. Berzunza-Cruz, M.; Bricaire, G.; Salaiza-Suazo, N.; Pérez- Montfort, R.; Becker, I. PCR for identification of species causing American cutaneous leishmaniasis. Parasitol. Res., 2009, 104, 691-699.
214. Bretagne, S.; Durand, R.; Olivi, M.; Garin, J.F.; Sulahian, A.; Rivollet, D.; Vidaud, M.; Deniau, M. Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice. Clin. Diagn. Lab. Immunol., 2001, 8, 828-831. (Pubitemid 32613716)
215. Nicholas, L.; Prina, E.; Lang, T.; Milon, G. Real-time PCR for detection and quantitation of Leishmania in mouse tissues. J. Clin. Microbiol., 2002, 40, 1666-1669. (Pubitemid 34493137)
216. Reimao, J.Q.; Colombo, F.A.; Pereira-Chioccola, V.L.; Tempone, A.G. In vitro and experimental therapeutic studies of the calcium channel blocker bepridil: Detection of viable Leishmania(L.) chagasi by real-time PCR. Exp. Parasitol., 2011, 128, 111-115.
217. Manna, L.; Reale, S.; Vitale, F.; Picillo, E.; Pavone, L.M.; Gravino, A.E. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol. Vet. J., 2008, 177, 279-282. (Pubitemid 351791588)
218. Hoet, S.; Opperdoes, F.; Brun, R.; Quetin-Leclercq, J. Natural products active against African trypanosomes: A step towards new drugs. Nat. Prod. Rep., 2004, 21,353-364. (Pubitemid 38865718)
219. Tempone, A.G.; Sartorelli, P.; Mady, C.; Fernandes, F. Natural products to anti-trypanosomal drugs: An overview of new drug prototypes for American Trypanosomiasis. Cardiovasc. Hematol. Agents Med. Chem., 2007, 5, 222-35. (Pubitemid 47180853)
220. Mishra, B.B.; Singh, R.K.; Srivastava, A.; Tripathi, V.J.; Tiwari, V.K. Fighting against Leishmaniasis: Search of alkaloids as future true potential anti-Leishmanial agents. Mini Rev. Med. Chem., 2009, 9, 107-123.
221. Kaur, K.; Jain, M.; Kaur, T.; Jain, R. Antimalarials from nature. Bioorg. Med. Chem., 2009, 17, 3229-3256.
222. Wright, C.W. Recent developments in research on terrestrial plants used for the treatment of malaria. Nat. Prod. Rep., 2010, 27, 961-968.
223. Ioset, J.-R. Natural products for neglected diseases: A review. Curr. Org. Chem., 2008, 12, 643-666.
224. Dewick, P.M. Medicinal Natural Products -A biosynthetic approach. (2nd ed.) John Wiley & Sons: Chichester, 2002.
225. Monzote, L.; Alarcón, O.; Setzer, W.N. Antiprotozoal activity of essential oils. Agric. Conspec. Sci., in press.
226. Cardoso, J.; Soares, M.J. In vitro effects of citral on Trypanosoma cruzi metacyclogenesis. Mem. Inst. Oswaldo Cruz, 2010, 105, 1026-1032.
227. Santin, M.R.; dos Santos, A.O.; Nakamura, C.V.; Filho, B.P.D.; Ferreira, I.C.P.; Ueda-Nakamura, T. In vitro activity of the essential oil of Cymbopogon citratus and its major component (citral) on Leishmania amazonensis. Parasitol. Res., 2009, 105, 1489-1496.
228. Escobar, P.; Leal, S.M.; Herrera, L.V.; Martinez, J.R.; Stashenko, E. Chemical composition and antiprotozoal activities of Colombian Lippia spp essential oils and their major components. Mem. Inst. Oswaldo Cruz, 2010, 105, 184-190.
229. Santoro, G.F.; Cardoso, M.G.; Guimarães, L.G.L.; Freire, J.M.; Soares, M.J. Anti-proliferative effect of the essential oil of Cymbopogon citrates (DC) Stapf (lemongrass) on intracellular amastigotes, bloodstream trypomastigotes and culture epimastigotes of Trypanosoma cruzi (Protozoa: Kinetoplastida). Parasitology, 2007, 134, 1649-1656. (Pubitemid 350194876)
230. Machado, M.; Santoro, G.; Sousa, M.C.; Salgueiro, L.; Cavaleiro, C. Activity of essential oils on the growth of Leishmania infantum promastigotes. Flavour Fragr. J., 2010, 25, 156-160.
231. Tariku, Y.; Hymete, A.; Hailu, A.; Rohloff, J. Essential-oil composition, antileishmanial, and toxicity study of Artemisia abyssinica and Satureja punctata ssp. punctata from Ethiopia. Chem. Biodivers., 2010, 7, 1009-1018.
232. Tchoumbougnang, F.; Zollo, P.H.A.; Dagne, E.; Mekonnen, Y. In vivo antimalarial activity of essential oils from Cymbopogon citratus and Ocimum gratissimum on mice infected with Plasmodium berghei. Planta Med., 2005, 71, 20-23. (Pubitemid 40223346)
233. do Socorro S.; Rosa, M.; Mondonça-Filho, R.R.; Bizzo, H.R.; de Almeida Rodrigues, I.; Soares, R.M.A.; Souto-Padrón, T.; Alviano, C.S.; Lopes, A.H.C.S. Antileishmanial activity of a linalool-rich essential oil from Croton cajucara. Antimicrob. Agents Chemother., 2003, 47, 1895-1901. (Pubitemid 36637811)
234. Zheljazkov, V.D.; Cantrell, C.L.; Tekwani, B.; Khan, S.I. Content, composition, and bioactivity of the essential oils of three basil genotypes as a function of harvesting. J. Agric. Food Chem., 2008, 56, 380-385. (Pubitemid 351212561)
235. de Almeida, I.; Sales Alviano, D.; Pereira Vieira, D.; Barreto Alves, P.; Fitzgerald Blank, A.; Lopes, A.H.C.S.; Sales Alviano, C.; do Socorro S. Rosa, M. Antigiardial activity of Ocimum basilicum essential oil. Parasitol. Res., 2007, 101, 443-452. (Pubitemid 46980546)
236. Santoro, G.F.; Cardoso, M.G.; Guimarães, L.G.L.; Mendonça, L.Z.; Soares, M.J. Trypanosoma cruzi: Activity of essential oils from Achillea millefolium L., Syzygium aromaticum L. and Ocimum basilicum L. on epimastigotes and trypomastigotes. Exp. Parasitol., 2007, 116, 283-290. (Pubitemid 46729534)
237. Boyom, F.F.; Ngouana, V.; Zollo, P.H.A.; Menut, C.; Bessiere, J.M.; Gut, J.; Rosenthal, P.J. Composition and anti-plasmodial activities of essential oils from some Cameroonian medicinal plants. Phytochemistry, 2003, 64, 1269-1275. (Pubitemid 37442434)
238. Kamatou, G.P.P.; Viljoen, A.M.; Figueiredo, A.C.; Tilney, P.M.; Van Zyl, R.L.; Barroso, J.G.; Pedro, L.G.; Van Vuuren, S.F. Trichomes, essential oil composition and biological activities of Salvia albicaulis Benth. and S. dolomitica Codd, two species from the Cape region of South Africa. S. Afr. J. Bot., 2007, 73, 102-108. (Pubitemid 44914154)
239. Hoet, S.; Stévigny, C.; Hérent, M.F.; Quetin-Leclercq, J. Antitrypanosomal compounds from the leaf essential oil of Strychnos spinosa. Planta Med., 2006, 72, 480-482.
240. Monzote, L.; Montalvo, A.M.; Almanonni, S.; Scull, R.; Miranda, M.; Abreu, J. Activity of the essential oil from Chenopodium ambrosioides grown in Cuba against Leishmania amazonensis. Chemotherapy, 2006, 52, 130-136. (Pubitemid 43760310)
241. Nibret, E.; Wink, M. Trypanocidal and antileukaemic effects of the essential oils of Hagenia abyssinica, Leonotis ocymifolia, Moringa stenopetala, and their main individual constituents. Phytomedicine, 2010, 17, 911-920.
242. Olagnier, D.; Costes, P.; Berry, A.; Linas, M.D.; Urrutigoity, M.; Dechy-Cabaret, O.; Benoit-Vical, F. Modifications of the chemical structure of terpenes in antiplasmodial and antifungal drug research. Bioorg. Med. Chem. Lett., 2007, 17, 6075-6078. (Pubitemid 47559131)
243. Sülsen, V.P.; Cazorla, S.I.; Frank, F.M.; Di Leo Lira, P.M.R.; Anesini, C.A.; Gutierrez Yapu, D.; Giménez Turba, A.; Bandoni, A.L.; Malchiodi, E.L.; Muschietti, L.V.; Martino, V.S. In vitro antiprotozoal activity and chemical composition of Ambrosia tenuifolia and A. scabra essential oils. Nat. Prod. Commun., 2008, 3, 557-562.
244. Mikus, J.; Harkenthal, M.; Steverding, D.; Reichling, J. In vitro effect of essential oils and isolated mono-and sesquiterpenes on Leishmania major and Trypanosoma brucei. Planta Med., 2000, 66, 366-368. (Pubitemid 30346305)
245. Su, V.; King, D.; Woodrow, I.; McFadden, G.; Gleadow, R. Plasmodium falciparum growth is arrested by monoterpenes from eucalyptus oil. Flavour Fragr. J., 2008, 23, 315-318.
246. Azizi, M.; Chizzola, R.; Ghani, A.; Oroojalian, F. Composition at different development stages of the essential oil of four Achillea species grown in Iran. Nat. Prod. Commun., 2010, 5, 283-290.
247. Santos, A.O.; Santin, A.C.; Yamaguchi, M.U.; Cortez, L.E.; Ueda-Nakamura, T.; Dias-Filho, B.P.; Nakamura, C.V. Antileishmanial activity of an essential oil from the leaves and flowers of Achillea millefolium. Ann. Trop. Med. Parasitol., 2010, 104, 475-483.
248. van Vuuren S.F.; Viljoen, A.M.; van Zyl, R.L.; van Heerden, F.R.; Baser, K.H.C. The antimicrobial, antimalarial and toxicity profiles of helihumulone, leaf essential oil and extracts of Helichrysum cymosum (L.) D. Don subsp. cymosum. S. Afr. J. Bot., 2006, 72, 287-290. (Pubitemid 43963578)
249. Moretti, A.D.; Filippo, L.; Elementi, S. Essential oils of Nigella sativa L. and Nigella damascena L. seed. J. Essent. Oil Res., 2004, 16, 182-183.
250. Wajs, A.; Bonikowski, R.; Kalemba, D. Composition of essential oil from seeds of Nigella sativa L. cultivated in Poland. Flavour Fragr. J., 2008, 23, 126-132. (Pubitemid 351596965)
251. Ekanem, J.T.; Yusuf, O.K. Some biochemical and haematological effects of black seed (Nigella sativa) oil on Trypanosoma brucei-infected rats. Afr. J. Biotechnol., 2008, 7, 153-157. (Pubitemid 351162541)
252. Machado, M.; Dinis, A.M.; Salgueiro, L.; Cavaleiro, C.; Custódio, J.B.A.; do Céu Sousa, M. Anti-Giardia activity of phenolic-rich essential oils: Effects of Thymbra capitata, Origanum virens, Thymus zygis subsp. sylvestris, and Lippia graveolens on trophozoites growth, viability, adherence, and ultrastructure. Parasitol. Res., 2010, 106, 1205-1215.
253. Santoro, G.F.; da Graças Cardoso, M.; Guimarães, L.G.L.; Salgado, A.P.S.P.; Menna-Barreto, R.F.S.; Soares, M.J. Effect of oregano (Origanum vulgare L.) and thyme (Thymus vulgaris L.) essential oils on Trypanosoma cruzi (Protozoa: Kinetoplastida) growth and ultrastructure. Parasitol. Res., 2007, 100, 783-790. (Pubitemid 46175244)
254. de Medeiros, M.d.G.F.; da Silva, A.C.; Citó, A.M.d.G.L.; Borges, A.R.; de Lima, S.G.; Lopes, J.A.D.; Figueiredo, R.C.B.Q. In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides Cham. Parasitol. Int., 2011, 60, 237-241.
255. Robledo, S.; Osorio, E.; Muñoz, D.; Jaramillo, L.M.; Restrepo, A.; Arango, G.; Vélez, I. In vitro and in vivo cytotoxicities and antileishmanial activities of thymol and hemisynthetic derivatives. Antimicrob. Agents Chemother., 2005, 49, 1652-1655. (Pubitemid 40463414)
256. Lopes, N.P.; Kato, M.J.; Andrade, E.H.d.A.; Maia, J.G.S.; Yoshida, M.; Planchart, A.R.; Katzin, A.M. Antimalarial use of volatile oil from leaves of Virola surinamensis (Rol.) Warb. by Waiãpi Amazon Indians. J. Ethnopharmacol., 1999, 67, 313-319. (Pubitemid 29469741)
257. Cheikh-Ali, Z.; Adiko, M.; Bouttier, S.; Bories, C.; Okpekon, T.; Poupon, E.; Champy, P. Composition and antimicrobial and remarkable antiprotozoal activities of the essential oil of rhizomes of Aframomum sceptrum K. Schum. (Zingiberaceae). Chem. Biodivers., 2011, 8, 658-667.
258. Tariku, Y.; Hymete, A.; Hailu, A.; Rohloff, J. In vitro evaluation of antileishmanial activity and toxicity of essential oils of Artemisia absinthium and Echinops kebericho. Chem. Biodivers., 2011, 8, 614-623.
259. Ortet, R.; Thomas, O.P; Regalado, E.L.; Pino, J.A.; Filippi, J.J.; Fernández, M.D. Composition and biological properties of the volatile oil of Artemisia gorgonum Webb. Chem. Biodivers., 2010, 7, 1325-1332.
260. Rodrigues Goulart, H.; Kimura, E.A.; Peres, V.J.; Couto, A.S.; Aquino Duarte, F.A.; Katzin, A.M. Terpenes arrest parasite development and inhibit biosynthesis of isoprenoids in Plasmodium falciparum. Antimicrob. Agents Chemother., 2004, 48, 2502-2509. (Pubitemid 38823417)
261. Arruda, D.C.; Miguel, D.C.; Yokoyama-Yasunaka, J.K.U.; Katzin, A.M.; Uliana, S.R.B. Inhibitory activity of limonene against Leishmania parasites in vitro and in vivo. Biomed. Pharmacother., 2009, 63, 643-649.
262. Hata, Y.; Zimmermann, S.; Quitschau, M.; Kaiser, M.; Hamburger, M.; Adams, M. Antiplasmodial and antitrypanosomal activity of pyrethrins and pyrethroids. J. Agric. Food Chem., 2011, 59, 9172-9176.
263. O'Neill, P.M.; Posner, G.H. A medicinal chemistry perspective on artemisinin and related endoperoxides. J. Med. Chem., 2004, 47, 2945-2964. (Pubitemid 38702690)
264. Li, J.; Zhou, B. Biological Actions of Artemisinin: Insights from Medicinal Chemistry Studies. Molecules, 2010, 15, 1378-1397.
265. Maude, R.J.; Woodrow, C.J.; White, L.J. Artemisinin Antimalarials: Preserving the "Magic Bullet". Drug Dev. Res., 2010, 71, 12-19.
266. Eastman, R.T.; Fidock, D.A. Artemisinin-based combination therapies: A vital tool in efforts to eliminate malaria. Nat. Rev. Microbiol., 2009, 7, 864-874.
267. Mishina, Y.V.; Krishna, S.; Haynes, R.K.; Meade, J.C. Artemisinins inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense in vitro growth. Antimicrob Agents Chemother., 2007, 51, 1852-1854. (Pubitemid 46744172)
268. Sen, R.; Bandyopadhyay, S.; Dutta, A.; Mandal, G.; Ganguly, S.; Saha, P.; Chatterjee, M. Artemisinin triggers induction of cell-cycle arrest and apoptosis in Leishmania donovani promastigotes. J. Med. Microbiol., 2007, 56, 1213-1218. (Pubitemid 47477194)
269. Avery, M.A.; Muraleedharan, K.M.; Desai, P.V.; Bandyopadhyaya, A.K.; Furtado, M.M.; Tekwani, B.L. Structure-Activity Relationships of the Antimalarial Agent Artemisinin. 8. Design, Synthesis, and CoMFA Studies toward the Development of Artemisinin-Based Drugs against Leishmaniasis and Malaria. J. Med. Chem., 2003, 46, 4244-4258. (Pubitemid 37153006)
270. Schmidt, T.J.; Nour, A.M.M.; Khalid, S.A.; Kaiser, M.; Brun, R. Quantitative structure-antiprotozoal activity relationships of sesquiterpene lactones. Molecules, 2009, 14, 2062-2076.
271. Izumi, E.; Morello, L.G.; Ueda-Nakamura, T.; Yamada-Ogatta, S.F.; Filho, B.P.D.; Cortez, D.A.G. Ferreira, I.C.; Morgado-Díaz, J.A.; Nakamura, C.V. Trypanosoma cruzi: Antiprotozoal activity of parthenolide obtained from Tanacetum parthenium (L.) Schultz Bip. (Asteraceae, Compositae) against epimastigote and amastigote forms. Exp. Parasitol., 2008, 118, 324-330. (Pubitemid 351192975)
272. Tiuman, T.S.; Ueda-Nakamura, T.; Garcia Cortez, D.A.; Dias Filho, B.P.; Morgado-Díaz, J.A.; de Souza, W.; Nakamura, C.V. Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium. Antimicrob. Agents Chemother., 2005, 49, 176-182. (Pubitemid 40065790)
273. Ortet, R.; Prado, S.; Mouray, E.; Thomas, O.P. Sesquiterpene lactones from the endemic Cape Verdean Artemisia gorgonum. Phytochemistry, 2008, 69, 2961-2965.
274. Gfkbulut, A.; Kaiser, M.; Brun, R.; Sarer, E.; Schmidt, T. J. 9-β-Hydroxyparthenolide esters from Inula montbretiana DC. and their antiprotozoal activity. Planta Med., in press. DOI: 10.1055/s-0031-1280371.
275. Graziose, R.; Rathinasabapathy, T.; Lategan, C.; Poulev, A.; Smith, P.J.; Grace, M.; Lila, M.A.; Raskin, I. Antiplasmodial activity of aporphine alkaloids and sesquiterpene lactones from Liriodendron tulipifera L. J. Ethnopharmacol., 2011, 133, 26-30.
276. Watt, J.M.; Breyer-Brandwyk, M.G. The Medicinal and Poisonous Plants of Southern and Eastern Africa; Livingston: London, 1962.
277. Pillay, P.; Vleggaar, R.; Maharaj, V.J.; Smith, P.J.; Lategan, C.A. Isolation and identification of antiplasmodial sesquiterpene lactones from Oncosiphon piluliferum. J. Ethnopharmacol., 2007, 112, 71-76. (Pubitemid 46702416)
278. Kim, J.J.; Chung, I.M.; Jung, J.C.; Kim, M.Y.; Moon, H.I. In vivo antiplasmodial activity of 11(13)-dehydroivaxillin from Carpesium ceruum. J. Enzyme Inhib. Med. Chem., 2009, 24, 247-250.
279. Chung, I.M.; Moon, H.I. Antiplasmodial activities of sesquiterpene lactone from Carpesium cernum. J. Enzyme Inhib. Med. Chem., 2009, 24, 131-135.
280. Goffin, E.; Ziemons, E.; De Mol, P.; de Madureira, M. do C.; Martins, A.P.; da Cunha, A.P.; Philippe, G.; Tits, M.; Angenot, L.; Frederich, M. In vitro antiplasmodial activity of Tithonia diversifolia and identification of its main active constituent: Tagitinin C. Planta Med., 2002, 68, 543-545. (Pubitemid 34774753)
281. François G.; Passreiter, C. M.; Woerdenbag, H. J.; Van Looveren, M. Antiplasmodial activities and cytotoxic effects of aqueous extracts and sesquiterpene lactones from Neurolaena lobata. Planta Med., 1996, 62, 126-129.
282. Berger, I.; Passreiter, C.M.; Cáceres, A.; Kubelka W. Antiprotozoal activity of Neurolaena lobata. Phytother. Res., 2001, 15, 327-330. (Pubitemid 32613102)
283. Moon, H.I. Antiplasmodial activity of ineupatorolides A from Carpesium rosulatum. Parasitol. Res., 2007, 100, 1147-1149.
284. Chung, I.M.; Kim, M.Y.; Moon, H.I. Antiplasmodial activity of sesquiterpene lactone from Carpesium rosulatum in mice. Parasitol. Res., 2008, 103, 341-344.
285. Oketch-Rabah, H.A.; Brøgger Christensen, S.; Frydenvang, K.; Dossaji, S.F.; Theander, T.G.; Cornett, C.; Watkins, W.M.; Kharazmi, A.; Lemmich, E. Antiprotozoal properties of 16,17-dihydrobrachycalyxolide from Vernonia brachycalyx. Planta Med., 1998, 64, 559-562. (Pubitemid 28383892)
286. Grael, C.F.; Vichnewski, W.; Souza, G.E.; Lopes, J.L.; Albuquerque, S.; Cunha, W.R. A study of the trypanocidal and analgesic properties from Lychnophora granmongolense (Duarte) Semir & Leitão Filho. Phytother. Res., 2000, 14, 203-206. (Pubitemid 30326016)
287. Grael, C.F.; Albuquerque, S.; Lopes, J.L. Chemical constituents of Lychnophora pohlii and trypanocidal activity of crude plant extracts and of isolated compounds. Fitoterapia, 2005, 76, 73-82. (Pubitemid 40139006)
288. Chiari, E.; de Oliveira, A.B.; Raslan, D.S.; Mesquita, A.A.; Tavares,
289. Vongvanich, N.; Kittakoop, P.; Charoenchai, P.; Intamas, S.; Sriklung, K.; Thebtaranonth, Y. Antiplasmodial, antimycobacterial, and cytotoxic principles from Camchaya calcarea. Planta Med., 2006, 72, 1427-30. (Pubitemid 46102401)
290. Saúde-Guimarães, D.A.; Perry, K.S.; Raslan, D.S.; Chiari, E.; Barrero, A.F.; Oltra, J.E. Complete assignments of 1H and 13C NMR data for trypanocidal eremantholide C oxide derivatives. Magn. Reson. Chem. 2007, 45,1084-1087.
291. Fuchino, H.; Koide, T.; Takahashi, M.; Sekita, S.; Satake, M. New sesquiterpene lactones from Elephantopus mollis and their leishmanicidal activities. Planta Med., 2001, 67, 647-653. (Pubitemid 32929577)
292. Schmidt, T.J. Toxic Activities of Sesquiterpene Lactones -Structural and Biochemical Aspects. Current Organic Chemistry. 1999, 3, 577-605.
293. Odonne, G.; Herbette, G.; Eparvier, V.; Bourdy, G.; Rojas, R.; Sauvain, M.; Stien, D. Antileishmanial sesquiterpene lactones from Pseudelephantopus spicatus, a traditional remedy from the Chayahuita Amerindians (Peru). Part III. J Ethnopharmacol., 2011, 137, 875-879.
294. Chea, A.; Hout, S.; Long, C.; Marcourt, L.; Faure, R.; Azas, N.; Elias, R. Antimalarial activity of sesquiterpene lactones from Vernonia cinerea. Chem. Pharm. Bull., 2006, 54, 1437-1439. (Pubitemid 44506579)
295. Fournet, A.; Muñoz, V.; Roblot, F.; Hocquemiller, R.; Cavé, A.; Gantier, J.C. Antiprotozoal activity of dehydrozaluzanin C, a sesquiterpene lactone isolated from Munnozia maronii (Asteraceae). Phytother. Res., 1993, 7, 111-115. (Pubitemid 23106460)
296. do Nascimento, A.M.; Siqueira Chaves, J.; Albuquerque, S.; Rodrigues de Oliveira, D.C. Trypanocidal properties of Mikania stipulacea and Mikania hoehnei isolated terpenoids. Fitoterapia, 2004, 75, 381-384. (Pubitemid 38670573)
297. Adams, M.; Zimmermann, S.; Küenzi, P.; Julianti, T.; Hata, Y.; Brun, R.; Hamburger, M. In vitro and in vivo activity of cynaropicrin against Trypanosoma brucei rhodesiense. Planta Med., 2010, 76, 1180.
298. Brengio, S.D.; Belmonte, S.A.; Guerreiro, E.; Giordano, O.S.; Pietrobon, E.O.; Sosa, M.A. The sesquiterpene lactone dehydroleucodine (DhL) affects the growth of cultured epimastigotes of Trypanosoma cruzi. J. Parasitol., 2000, 86, 407-412. (Pubitemid 30208404)
299. Barrera, P.A.; Jimenez-Ortiz, V.; Tonn, C.; Giordano, O.; Galanti, N.; Sosa, M.A. Natural sesquiterpene lactones are active against Leishmania mexicana. J. Parasitol., 2008, 94, 1143-1149.
300. Bischoff, T.A.; Kelley, C.J.; Karchesy, Y.; Laurantos, M.; Nguyen-Dinh, P.; Arefi, AG. Antimalarial activity of lactucin and lactucopicrin: Sesquiterpene lactones isolated from Cichorium intybus L. J. Ethnopharmacol., 2004, 95, 455-457. (Pubitemid 39422708)
301. da Silva, B.P.; Cortez, D.A.; Violin, T.Y.; Dias Filho, B.P.; Nakamura, C.V.; Ueda-Nakamura, T.; Ferreira, I.C. Antileishmanial activity of a guaianolide from Tanacetum parthenium (L.) Schultz Bip. Parasitol. Int., 2010, 59, 643-646.
302. Maas, M.; Hensel, A.; Da Costa, F.B.; Brun, R.; Kaiser, M.; Schmidt, T.J. An unusual dimeric guaianolide with antiprotozoal activity and further sesquiterpene lactones from Eupatorium perfoliatum. Phytochemistry, 2011, 72, 635-644.
303. Schmidt, T.J.; Willuhn, G.; Brun, R.; Khalid, S.A. Antitrypanosomal Activity of Helenalin and some Related Sesquiterpene Lactones. Planta Med., 2002, 68, 750-751. (Pubitemid 35013392)
304. Jimenez-Ortiz, V.; Brengio, S.D.; Giordano, O.; Tonn, C.; Sánchez, M.; Burgos, M.H.; Sosa, M.A. The trypanocidal effect of sesquiterpene lactones helenalin and mexicanin on cultured epimastigotes. J. Parasitol., 2005, 91, 170-174. (Pubitemid 40804317)
305. François, G.; Passreiter, C.M. Pseudoguaianolide sesquiterpene lactones with high activities against the human malaria parasite Plasmodium falciparum. Phytother. Res., 2004, 18, 184-186. (Pubitemid 38380618)
306. Aponte, J.C.; Yang, H.; Vaisberg, A.J.; Castillo, D.; Málaga, E.; Verástegui, M.; Casson, L.K.; Stivers, N.; Bates, P.J.; Rojas, R.; Fernandez, I.; Lewis, W.H.; Sarasara, C.; Sauvain, M.; Gilman, R.H.; Hammond, G.B. Cytotoxic and anti-infective sesquiterpenes present in Plagiochila disticha (Plagiochilaceae) and Ambrosia peruviana (Asteraceae). Planta Med., 2010, 76, 705-707.
307. Sülsen, V.P.; Frank, F.M.; Cazorla, S.I.; Anesini, C.A.; Malchiodi, E.L.; Freixa, B.; Vila, R.; Muschietti, L.V.; Martino, V.S. Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae). Antimicrob. Agents Chemother., 2008, 52, 2415-2419. (Pubitemid 351915670)
308. Sülsen, V.; Barrera, P.; Muschietti, L.; Martino, V.; Sosa, M. Antiproliferative effect and ultrastructural alterations induced by psilostachyin on Trypanosoma cruzi. Molecules, 2010, 15, 545-553.
309. Sülsen, V.P.; Frank, F.M.; Cazorla, S.I.; Barrera, P.; Freixa, B.; Vila, R.; Sosa, M.A.; Malchiodi, E.L,; Muschietti, L.V.; Martino, V.S. Psilostachyin C: A natural compound with trypanocidal activity. Int. J. Antimicrob. Agents, 2011, 37, 536-543.
310. Lang, G.; Passreiter, C.M.; Wright, C.W.; Filipowicz, N.H.; Addae-Kyereme, J.; Medinilla BE, Castillo JJ. Antiplasmodial activities of sesquiterpene lactones from Eupatorium semialatum. Z. Naturforsch. C., 2002, 57, 282-286. (Pubitemid 34489922)
311. That, Q.T.; Jossang, J.; Jossang, A.; Kim, P.P.; Jaureguiberry, G. Wedelolides A and B: Novel sesquiterpene delta-lactones, (9R)-eudesman-9,12- olides, from Wedelia trilobata. J. Org. Chem., 2007, 72, 7102-7105. (Pubitemid 47425476)
312. Pedersen, M.M.; Chukwujekwu, J.C.; Lategan, C.A.; Staden, J.; Smith, P.J.; Staerk, D. Antimalarial sesquiterpene lactones from Distephanus angulifolius. Phytochemistry, 2009, 70, 601-607.
313. Kraft, C.; Jenett-Siems, K.; Siems, K.; Jakupovic, J.; Mavi, S.; Bienzle, U.; Eich, E. In vitro antiplasmodial evaluation of medicinal plants from Zimbabwe. Phytother. Res., 2003, 17, 123-128. (Pubitemid 36262259)
314. Acebey, L.; Jullian, V.; Sereno, D.; Chevalley, S.; Estevez, Y.; Moulis, C.; Beck, S.; Valentin, A.; Gimenez, A.; Sauvain, M. Anti-leishmanial lindenane sesquiterpenes from Hedyosmum angustifolium. Planta Med., 2010, 76, 365-368.
315. Karioti, A.; Skaltsa, H.; Kaiser, M.; Tasdemir, D. Trypanocidal, leishmanicidal and cytotoxic effects of anthecotulide-type linear sesquiterpene lactones from Anthemis auriculata. Phytomedicine, 2009, 16, 783-787.
316. Karioti, A.; Skaltsa, H.; Zhang, X.; Tonge, P.J.; Perozzo, R.; Kaiser, M.; Franzblau, S.G.; Tasdemir D. Inhibiting enoyl-ACP reductase (FabI) across pathogenic microorganisms by linear sesquiterpene lactones from Anthemis auriculata. Phytomedicine, 2008, 15, 1125-1129.
317. Karioti, A.; Skaltsa, H.; Linden, A.; Perozzo, R.; Brun, R.; Tasdemir D. Anthecularin: A novel sesquiterpene lactone from Anthemis auriculata with antiprotozoal activity. J. Org. Chem., 2007, 72, 8103-8106. (Pubitemid 47582601)
318. Montamat, E.E.; Burgos, C.; Gerez de Burgos, N.M.; Rovai, L.E.; Blanco, A; Segura, E.L. Inhibitory action of gossypol on enzymes and growth of Trypanosoma cruzi. Science, 1982, 218, 288-289. (Pubitemid 12030600)
319. Eid, J.E.; Ueno, H.; Wang, C.C.; Donelson, J.E. Gossypol-induced death of African trypanosomes. Exp. Parasitol., 1988, 66, 140-142.
320. Wang, X.; Beckham, T.H.; Morris, J.C.; Chen, F.; Gangemi, J.D. Bioactivities of gossypol, 6-methoxygossypol, and 6,6'-dimethoxygossypol. J. Agric. Food Chem., 2008, 56, 4393-4398.
321. Sprogøe, K.; Stærk, D.; Ziegler, H.L.; Høgh Jensen, T.; Holm-Møller, S.B.; Jaroszewski, J.W. Combining HPLC-PDA-MS-SPE-NMR with Circular Dichroism for Complete Natural Product Characterization in Crude Extracts: Levorotatory Gossypol in Thespesia danis. J. Nat. Prod., 2008, 71, 516-519. (Pubitemid 351656178)
322. Arruda, D.C.; D'Alexandri, F.L.; Katzin, A.M.; Uliana, S.R. Antileishmanial activity of the terpene nerolidol. Antimicrob. Agents Chemother. 2005, 49, 1679-1687. (Pubitemid 40631574)
323. Morales-Yuste, M.; Morillas-Márquez, F.; Martín- Sánchez, J.; Valero-López, A.; Navarro-Moll, M.C. Activity of (-)alpha-bisabolol against Leishmania infantum promastigotes. Phytomedicine, 2010, 17, 279-281.
324. Gachet, M.S.; Kunert, O.; Kaiser, M.; Brun, R.; Zehl, M.; Keller, W.; Muñoz, R.A.; Bauer, R.; Schuehly, W. Antiparasitic compounds from Cupania cinerea with activities against Plasmodium falciparum and Trypanosoma brucei rhodesiense. J. Nat. Prod., 2011, 74, 559-566.
325. Kanokmedhakul, S.; Kanokmedhakul, K.; Lekphrom, R. Bioactive constituents of the roots of Polyalthia cerasoides. J. Nat. Prod., 2007, 70, 1536-1538. (Pubitemid 47584608)
326. Rücker, G.; Schenkel, E.P.; Manns, D.; Mayer, R.; Heiden, K.; Heinzmann, B.M. Sesquiterpene peroxides from Senecio selloi and Eupatorium rufescens. Planta Med., 1996, 62, 565-566. (Pubitemid 27006699)
327. Biavatti, M.W.; Vieira, P.C.; da Silva, M.F.G.; Fernandes, J.B.; Albuquerque, S.; Magalhães, C.M.; Pagnocca, F.C. Chemistry and bioactivity of Raulinoa echinata Cowan, an endemic Brazilian Rutaceae species. Phytomedicine, 2001, 8, 121-124. (Pubitemid 32267096)
328. Tchuendem, M.H.; Mbah, J.A.; Tsopmo, A.; Ayafor, J.F.; Sterner, O.; Okunjic, C.C.; Iwu, M.M.; Schuster, B.M. Anti-plasmodial sesquiterpenoids from the African Reneilmia cincinnata. Phytochemistry, 1999, 52, 1095-1099. (Pubitemid 30016471)
329. Kiuchi, F.; Matsuo, K.; Ito, M.; Qui, T.K.; Honda, G. New sesquiterpene hydroperoxides with trypanocidal activity from Pogostemon cablin. Chem. Pharm. Bull., 2004, 52, 1495-1496. (Pubitemid 41364436)
330. Villaescusa-Castillo, L.; Díaz-Lanza, A.M.; Gasquet, M.; Delmas, F.; Ollivier, E.; Bernabé, M.; Faure, R.; Elias, R.; Balansard, G. Antiprotozoal activity of sesquiterpenes from Jasonia glutinosa. Pharm Biol., 2000, 38, 176-180. (Pubitemid 30616119)
331. Rukunga, G.M.; Muregi, F.W.; Omar, S.A.; Gathirwa, J.W.; Muthaura, C.N.; Peter, M.G.; Heydenreich, M.; Mungai, G.M. Anti-plasmodial activity of the extracts and two sesquiterpenes from Cyperus articulatus. Fitoterapia, 2008, 79, 188-190.
332. Rubio, J.; Calderón, J.S.; Flores, A.; Castroa, C.; Céspedes, C.L. Trypanocidal activity of oleoresin and terpenoids isolated from Pinus oocarpa. Z. Naturforsch. C. 2005, 60, 711-716. (Pubitemid 41615699)
333. Henchiri, H.; Bodo, B.; Deville, A.; Dubost, L.; Zourgui, L.; Raies, A.; Grellier, P.; Mambu, L. Sesquiterpenoids from Teucrium ramosissimum. Phytochemistry, 2009, 70, 1435-1441.
334. Thebtaranonth, C.; Thebtaranonth, Y.; Wanauppathamkul, S.; Yuthavong, Y. Antimalarial sesquiterpenes from tubers of Cyperus rotundus: Structure of 10,12-peroxycalamenene, a sesquiterpene endoperoxide. Phytochemistry, 1995, 40, 125-128.
335. Corrêa, D.S.; Tempone, A.G.; Reimão, J.Q.; Taniwaki, N.N.; Romoff, P.; Fávero, O.A.; Sartorelli, P.; Mecchi, M.C.; Lago, J.H. Anti-leishmanial and anti-trypanosomal potential of polygodial isolated from stem barks of Drimys brasiliensis Miers (Winteraceae). Parasitol. Res., 2011, 109, 231-236.
336. Wube, A.A.; Bucar, F.; Gibbons, S.; Asres, K.; Rattray, L.; Croft, S.L. Antiprotozoal activity of drimane and coloratane sesquiterpenes towards Trypanosoma brucei rhodesiense and Plasmodium falciparum in vitro. Phytother. Res., 2010, 24, 1468-1472.
337. Pérez-Victoria, J.M.; Tincusi, B.M.; Jiménez, I.A.; Bazzocchi, I.L.; Gupta, M.P.; Castanys, S.; Gamarro, F.; Ravelo, A.G. New natural sesquiterpenes as modulators of daunomycin resistance in a multidrug-resistant Leishmania tropica line. J. Med. Chem., 1999, 42, 4388-4393. (Pubitemid 29504142)
338. Kennedy, M.L.; Cortés-Selva, F.; Pérez-Victoria, J.M.; Jiménez, I.A.; González, A.G.; Muñoz, O.M.; Gamarro, F.; Castanys, S.; Ravelo, A.G. Chemosensitization of a multidrug-resistant Leishmania tropica line by new sesquiterpenes from Maytenus magellanica and Maytenus chubutensis. J. Med. Chem., 2001, 44, 4668-4676. (Pubitemid 33144476)
339. Delgado-Méndez, P.; Herrera, N.; Chávez, H.; Estévez-Braun, A.; Ravelo, A.G.; Cortes, F.; Castanys, S.; Gamarro, F. New terpenoids from Maytenus apurimacensis as MDR reversal agents in the parasite Leishmania. Bioorg. Med. Chem., 2008, 16, 1425-1430. (Pubitemid 351191760)
340. Munoz-Martinez, F.; Lu,P.; Corte's-Selva,F.; Perez-Victoria,J.M.; Jimenez, I.A.; Ravelo, A.G.; Sharom, F.J.; Gamarro,F.; Castanys, S. Celastraceae Sesquiterpenes as a New Class of Modulators That Bind Specifically to Human P-Glycoprotein and Reverse Cellular Multidrug Resistance. Cancer Res., 2004, 64, 7130-7138. (Pubitemid 39331027)
341. Cortés-Selva, F.; Campillo, M.; Reyes, C.P.; Jiménez, I.A.; Castanys, S.; Bazzocchi, I.L.; Pardo, L.; Gamarro, F.; Ravelo, A.G. SAR studies of dihydro-beta-agarofuran sesquiterpenes as inhibitors of the multidrugresistance phenotype in a Leishmania tropica line overexpressing a Pglycoprotein-like transporter. J. Med. Chem., 2004, 47, 576-587. (Pubitemid 38129716)
342. Topcu, G.; Aydogmus, Z.; Imre, S.; Gören, A.C.; Pezzuto, J.M.; Clement, J.A.; Kingston, D.G. Brominated sesquiterpenes from the red alga Laurencia obtusa. J. Nat. Prod., 2003, 66, 1505-1508. (Pubitemid 37490405)
343. Dos Santos, A.O.; Veiga-Santos, P.; Ueda-Nakamura, T.; Filho, B.P.; Sudatti, D.B.; Bianco, E.M.; Pereira, R.C.; Nakamura, C.V. Effect of elatol, isolated from red seaweed Laurencia dendroidea, on Leishmania amazonensis. Mar. Drugs, 2010, 8, 2733-2743.
344. da Silva Machado, F.L.; Pacienza-Lima, W.; Rossi-Bergmann, B.; de Souza Gestinari, L.M.; Fujii, M.T.; Campos de Paula, J.; Soares Costa, S.; Lopes, N.P.; Kaiser, C.R.; Soares, A.R. Antileishmanial Sesquiterpenes from the Brazilian Red Alga Laurencia dendroidea. Planta Med., 2011, 77, 733-735.
345. Izumi, E.; Ueda-Nakamura, T.; Dias Filho, B.P.; Veiga Júnior, V.F.; Nakamura, C.V. Natural products and Chagas' disease: A review of plant compounds studied for activity against Trypanosoma cruzi. Nat. Prod. Rep., 2011, 28, 809-823.
346. Uchiyama, N. Antichagasic activities of natural products against Trypanosoma cruzi. J. Health Sci., 2009, 55, 31-39.
347. Nogueira, C.R.; Lopes, L.M.X. Antiplasmodial natural products. Molecules, 2011, 16, 2146-2190.
348. Bero, J.; Quetin-Leclercq, J. Natural products published in 2009 from plants traditionally used to treat malaria. Planta Med., 2011, 77, 631-640.
349. Calcul, L.; Tenney, K.; Ratnam, J.; McKerrow, J.H.; Crews, P. Structural variations to the 9-N-methyladeninium diterpenoid hybrid commonly isolated from Agelas sponges. Aust. J. Chem., 2010, 63, 915-921.
350. Kayser, O.; Kiderlen, A.F.; Bertels, S.; Siems, K. Antileishmanial activities of aphidicolin and its semisynthetic derivatives. Antimicrob. Agents Chemother., 2001, 288-292. (Pubitemid 32039128)
351. Da Costa, F.B.; Albuquerque, S.; Vichnewski, W. Diterpenes and synthetic derivatives from Viguiera aspillioides with trypanomicidal activity. Planta Med., 1996, 62, 557-559. (Pubitemid 27006696)
352. Batista, R.; Humberto, J.L.; Chiari, E.; Oliveira, A.B. Synthesis and trypanocidal activity of ent-kaurane glycosides. Bioorg. Med. Chem., 2007, 15, 381-391. (Pubitemid 44738567)
353. Cheikh-Ali, Z.; Okpekon, T.; Roblot, F.; Bories, C.; Cardao, M.; Jullian, J.-C; Poupon, E.; Champy, P. Labdane diterpenoids from Aframomum sceptrum: NMR study and antiparasitic activities. Phytochem. Lett., 2011, in press, doi:10.1016/j.phytol.2011.04.006.
354. Sob, S.V.T.; Tane, P.; Ngadjui, B.T.; Connolly, J.D.; Ma, D. Trypanocidal labdane diterpenoids from the seeds of Aframomum aulacocarpos (Zingiberaceae). Tetrahedron, 2007, 63, 8993-8998. (Pubitemid 47087852)
355. Schmidt, T.J.; Kaiser, M.; Brun, R. Complete structural assignment of serratol, a cembrane-type diterpene from Boswellia serrata, and evaluation of its antiprotozoal activity. Planta Med., 2011, 77, 849-850.
356. Alves, T.M.A.; Chaves, P.P.G.; Santos, L.M.S.T.; Nagem, T.J.; Murta, S.M.F.; Ceravolo, I.P.; Romanha, A.J.; Zani, C.L. A diterpene from Mikania obtusata active on Trypanosoma cruzi. Planta Med., 1995, 61, 85-86.
357. Haraguchi, S.K.; Silva, A.A.; Vidotti, G.J.; Santos, P.V.; Garcia, F.P.; Pedroso, R.B.; Nakamura, C.V.; Oliveira, C.M.A.; Silva, C.C. Antitrypanosomal activity of novel benzaldehyde-thiosemicarbazone derivatives from kaurenoic acid. Molecules, 2011, 16, 1166-1180.
358. Ambrósio, S.R.; Arakawa, N.S.; Esperandim, V.R.; Albuquerque, S.; Da Costa, F.B. Trypanocidal activity of pimarane diterpenes from Viguiera arenaria (Asteraceae). Phytother. Res., 2008, 22, 1413-1415.
359. Pinheiro, M.L.B.; Xavier, C.M.; Souza, A.D.L.; Rabelo, D.M.; Batista, C.L.; Batista, R.L.; Costa, E.V.; Campos, F.R.; Barison, A.; Valdez, R.H.; Ueda-Nakamura, T.; Nakamura, C.V. Acanthoic acid and other constituents from the stem of Annona amazonica (Annonaceae). J. Braz. Chem. Soc., 2009, 20, 1095-1102.
360. Herrera, J.C.; Tronconea, G.; Henríquez, D.; Urdaneta, N. Trypanocidal activity of abietane diterpenoids from the roots of Craniolaria annua. Z. Naturforsch., 2008, 63c, 821-829.
361. Campos, M.C.O.; Salomão, K.; Castro-Pinto, D.B.; Leon, L.L.; Barbosa, H.S.; Maciel, M.A.M.; Castro, S.L. Croton cajucara crude extract and isolated terpenes: Activity on Trypanosoma cruzi. Parasitol. Res., 2010, 107, 1193-1204.
362. Sartorelli, P.; Carvalho, C.S.; Reimão, J.Q.; Lorenzi, H.; Tempone, A.G. Antitrypanosomal activity of a diterpene and lignans isolated from Aristolochia cymbifera. Planta Med., 2010, 76, 1454-1456.
363. Kennedy, M.L.; Cortés, F.; Piñero, J.E.; Castanys, S; López-Arencibia, A.; Gamarro, F.; Bezzocchi, I.L.; Jiménez, I.A.; Leishmanicidal and reversal multidrug resistance constituents from Aeonium lindleyi. Planta Med., 2011, 77, 77-80.
364. Fokialakis, N.; Kalpoutzakis, E.; Tekwani, B.L.; Skaltsounis, A.L.; Duke, S.O. Antileishmanial activity of natural diterpenes from Cistus sp. And semisynthetic derivatives thereof. Biol. Pharm. Bull., 2006, 29, 1775-1778. (Pubitemid 44166390)
365. Misra, P.; Sashidhara, K.V.; Singh, S.P.; Kumar, A.; Gupta, R.; Chaudhaery, S.S.; Gupta, S.S.; Majumder, H.K.; Saxena, A.K.; Dube, A. 16a-Hydroxycleroda-3,13(14)Z-dien-15,16-olide from Polyalthia longifolia: A safe and orally active antileishmanial agent. Br. J. Pharmacol., 2010, 159, 1143-1150.
366. Cota, B.B.; Oliveira, D.M.; Siqueira, E.P.; Souza-Fagundes, E.M.; Pimenta, A.M.C.; Santos, D.M.; Rabello, A.; Zani, C.L. New cassane diterpenes from Caesalpinia echinata. Fitoterapia, 2011, 82, 969-975.
367. Samoylenko, V.; Dunbar, D.C.; Gafur, Md.A.; Khan, S.I.; Ross, S.A.; Mossa, J.S.; El-Feraly, F.S.; Tekwani, B.L.; Bosselaers, J.; Muhammad, I. Antiparasitic, nematicidal and antifouling constituents from Juniperus berries. Phytother. Res., 2008, 22, 1570-1576.
368. Mishra, K.; Dash, A.P.; Dey, N. Andrographolide: A novel antimalarial diterpene lactone compound from Andrographis paniculata and its interaction with curcumin and artesunate. J. Trop. Med., 2011, 579518, doi:10.1155/2011/579518.
369. Sebisubi, F.M.; Odyek, O.; Anokbonggo, W.W.; Ogwal-Okeng, J.; Carcache-Blanco, E.J.; Ma, C.; Orjala, J.; Tan, G.T. Antimalarial activity of Aspilia pruliseta, a medicinal plant from Uganda. Planta Med., 2010, 76, 1870-1873.
370. Lekphrom, R.; Kanokmedhakul, S.; Kanokmedhakul, K. Bioactive diterpenes from the aerial parts of Anisochilus harmandii. Planta Med., 2010, 76, 726-728.
371. Matsuno, Y.; Deguchi, J.; Hirasawa, Y.; Ohyama, K.; Toyoda, H.; Hirobe, C.; Ekasari, W.; Widyawaruyanti, A.; Zaini, N.C.; Morita, H. Sucutiniranes A and B, new cassane-type diterpenes from Bowdichia nitida. Bioorg. Med. Chem. Lett., 2008, 18, 3774-3777. (Pubitemid 351802254)
372. Peixoto, J.A.; Silva, M.L.A.; Crotti, A.E.M.; Veneziani, R.C.S.; Gimenez, V.M.M.; Januário, A.H.; Groppo, M.; Magalhães, L.G.; Santos, F.F., Albuquerque, S.; Silva-Filho, A.A.; Cunha, W.R. Antileishmanial activity of the hydroalcoholic extract of Miconia langsdorffii, isolated compounds, and semi-synthetic derivatives. Molecules 2011, 16, 1825-1833.
373. Leite, J.P.V.; Oliveira, A.B.; Lombardi, J.A.; Filho, J.D.S.; Chiari, E. Trypanocidal activity of triterpenes from Arrabidaea triplinervia and derivatives. Biological Pharmaceutical Bulletin 2006, 29, 2307-2309. (Pubitemid 44690963)
374. Cunha, W.R.; Crevelin, E.J.; Arantes, G.M.; Crotti, A.E.M.; Silva, M.L.A.; Furtado, N.A.J.C.; Albuquerque, S. Ferreira, D.S. A study of the trypanocidal activity of triterpene acids isolated from Miconia species. Phytother. Res., 2006, 20, 474-478. (Pubitemid 43953401)
375. Camacho, M.R.; Mata, R.; Castaneda, P.; Kirby, G.C.; Warhurst, D.C.; Croft, S.L.; Phillipson, J.D. Bioactive compounds from Celaenodendron mexicanum. Planta Med., 2000, 66, 463-468. (Pubitemid 30413510)
376. Cunha, W.R.; Martins, C.; Ferreira, D.S.; Crotti, A.E.M.; Lopes, N.P.; Albuquerque, S. In vitro trypaodical activity of triterpenes from Miconia species. Planta Med., 2003, 69, 470-472. (Pubitemid 36774193)
377. Takahashi, M.; Fuchino, H.; Sekita, S.; Satake. M. In vitro leishmanicidal activity of some scarce natural products. Phytother. Res., 2004, 18, 573-578. (Pubitemid 39079156)
378. Uchôa, V.T.; Paula, R.C.; Krettli, L.G.; Santana, A.E.G.; Krettli, A.U. Antimalarial activity of compounds and mixed fractions of Cecropia pachystachya. Drug Dev. Res., 2010, 71, 82-91.
379. Andrade, S.F.; Silva-Filho, A.A.; Resende, D.O.; Silva, M.L.A.; Cunha, W.R.; Nanayakkara, N.P.D.; Bastos, J.K. Antileishmanial, antimalarial and antimicrobial activities of the extract and isolated compounds from Austroplenckia populnea (Celastraceae). Z. Naturforsch. C, 2008, 63, 497-502.
380. Lião, L.M.; Silva, G.A.; Monteiro, M.R.; Albuquerque, S. Trypanocidal activity of quinonemethide triterpenoids from Cheiloclinium cognatum (Hippocrateaceae). Z. Natuforsch. C, 2008, 63, 207-210.
381. Thiem, D.A.; Sneden, A.T.; Khan, S.I.; Tekwani, B.L. Bisnortriterpenes from Salacia madagascariensis. J. Nat. Prod., 2005, 68, 251-254. (Pubitemid 40299817)
382. Danelli, M.G.M.; Soares, D.C.; Abreu, H.S.; Peçanha, L.M.T.; Saraiva, E.M. Leishmanicidal effect of LLD-3 (1), a nor-triterpene isolated from Lophanthera lactescens. Phytochemistry 2009, 70, 608-614.
383. Alakurtti, S.; Heiska, T.; Kiriazis, A.; Sacerdoti-Sierra, N.; Jaffe, C. L.; Yli-Kauhaluoma, J. Synthesis and anti-leishmanial activity of heterocyclic betulin derivatives. Bioorg. Med. Chem, 2010, 18, 1573-1582.
384. Campos, F.R.; Januáio, A.H.; Rosas, L.V.; Nascimento, S.K.R.; Pereira, P.S.; França, S.C.; Cordeiro, M.S.C.; Toldo, M.P.A.; Albuquerque, S. Trypanocidal activity of extracts and fractions of Bertholletia excelsa. Fitoterapia, 2005, 76, 26-29. (Pubitemid 40138998)
385. Domínguez-Carmona, D.B.; Escalante-Erosa, F.; García-Sosa, K.; Ruiz-Pinell, G.; Gutierrez-Yapu, D.; Chan-Bacab, M.J.; Giménez-Turba, A.; Peña-Rodríguez, L.M. Antiprotozoal activity of Betulinic acid derivatives. Phytomedicine, 2010, 17, 379-382.
386. Teles, C.B.G.; Moreira, L.S.; Silva, A.A.E.; Facundo, V.A.; Zuliani, J.P.; Stábelia, R.G.; Silva-Jardim, I. Activity of the lupane isolated from Combretum leprosum against Leishmania amazonensis promastigotes. J. Braz. Chem. Soc., 2011, 22, 936-942.
387. Ma, C.; Zhang, H.J.; Tan, G.T.; Hung, N.V.; Cuong, N.M.; Soejarto, D.D.; Fong, H.H.S. Antimalarial compounds from Grewia bilamellata. J. Nat. Prod., 2006, 69, 346-350.
388. Camacho, M.R.; Phillipson, J.D.; Croft, S.L.; Kirby, G.C.; Warhurst, D.C.; Solis, P.N. Terpenoids from Guarea rhophalocarpa. Phytochemistry, 2001, 56, 203-210. (Pubitemid 32118603)
389. Leite, A.C.; Ambrozin, A.R.P.; Fernandes, J.B.; Vieira, P.C.; Silva, M.F.G.F.; Albuquerque, S. Trypanocidal activity of limonoids and triterpenes from Cedrela fissilis. Planta Med., 2008, 74, 1795-1799.
390. Adams, M.; Gschwind, S.; Zimmermann, S.; Kaiser, M.; Hamburger, M. Renaissance remedies: Antiplasmodial triterpenoids from Alisma plantagoaquatica L. (Alismataceae). J. Ethnopharmacol., 2011, 135, 43-47.
391. Ramalhete, C.; Lopes, D.; Mulhovo, S.; Molnár, J.; Rosário, V.E.; Ferreira, M.J.U. New antimalarials with a triterpenic scaffold from Momordica balsamina. Bioorg. Med. Chem., 2010, 18, 5254-5260.
392. Ramalhete, C.; Lopes, D.; Molnár, J.; Mulhovo, S.; Rosário, V.E.; Ferreira, M.J.U. Karavilagenin C derivatives as antimalarials. Bioorg. Med. Chem., 2011, 19, 330-338.
393. Banzouzi, J.T.; Soh, P.N.; Mbatchi, B.; Cavé, A.; Ramos, S.; Retailleau, P.; Rakotonandrasana, O.; Berry, A.; Benoit-Vical, F. Cogniauxia podolaena: Biossay-guided fractionation of defoliated stems, isolation of active compounds, antiplasmodial activity and cytotoxicity. Planta Med., 2008, 74, 1453-1456.
394. Takahara, M.; Kusano, A.; Shibano, M.; Kusano, G.; Koizumi, K.; Suzuki, R.; Kim, H.-S.; Wataya, Y. Antimalarial activity and nucleoside transport inhibitory activity of the triterpenic constituents of Cimicifuga ssp. Biol. Pharm. Bull., 1998, 21, 823-828. (Pubitemid 28407228)
395. Choudhary, M.I.; Jan, S.; Abbaskhan, A.; Musharraf, S.G.; Samreen; Sattar, S. A.; Rahman, A.-U. Cycloartane Triterpenoids from Astragalus bicuspis. J. Nat. Prod., 2008, 71, 1557-1560
396. Kitagawa, I.; Mahmud, T.; Simanjuntak, P.; Hori, K.; Uji, T.; Shibuya, H. Indonesian medicinal plants. VIII. Chemical structures of three new triterpenoids, bruceajavanin A, dihydrobruceajavanin A, and bruceajavanin B, a new alkaloidal glycoside, bruceacanthinoside, from the stems of Brucea javanica (Simaroubaceae). Chem. Pharm. Bull., 1994, 42, 1416-1421. (Pubitemid 24244085)
397. Benoit-Vical, F.; Imbert, C.; Bonfils, J. P.; Sauvaire, Y. Antiplasmodial and antifungal activities of iridal, a plant triterpenoid. Phytochemistry, 2003, 62, 747-751. (Pubitemid 36227770)
398. Chianese, G.; Yerbanga, S. R.; Lucantoni, L.; Habluetzel, A.; Basilico, N.; Taramelli, D.; Fattorusso, E.; Taglialatela-Scafati, O. Antiplasmodial triterpenoids from the fruits of neem, Azadirachta indica. J. Nat. Prod., 2010, 73, 1448-1452.
399. Pereira da Silva, V.; Oliveira, R. R.; Figueiredo, M. R. Isolation of limonoids from seeds of Carapa guianensis Aublet (Meliaceae) by high-speed countercurrent chromatography. Phytochem. Anal., 2009, 20, 77-81.
400. Lee, S.-E.; Kim, M.-R.; Kim, J.-H.; Takeoka, G. R.; Kim, T.-W.; Park, B.-S. Antimalarial activity of anthothecol derived from Khaya anthotheca (Meliaceae). Phytomedicine, 2008, 15, 533-535. (Pubitemid 351784547)
401. Omar, S.; Zhang, J.; MacKinnon, S.; Leaman, D.; Durst, T.; Philogene, B. J. R.; Arnason, J. T.; Sanchez-Vindas, P. E.; Poveda, L.; Tamez, P. A.; Pezzuto, J. M. Traditionally-used antimalarials from the Meliaceae. Curr. Top. Med. Chem., 2003, 3, 133-139.
402. Khalid, S.A., Farouk, A., Geary, T.G.; Jensen, J.B. Potential antimalarial candidates from African plants: An in vitro approach using Plasmodium falciparum. J. Ethnopharmacol., 1986, 15, 201-209. (Pubitemid 16129224)
403. MacKinnon, S.; Durst, T.; Arnason, J. T.; Angerhofer, C.; Pezzuto, J.; Sanchez-Vindas, P. E.; Poveda, L. J.; Gbeaessor, M. Antimalarial activity of tropical Meliaceae extracts and gedunin derivatives. J. Nat. Prod., 1997, 60, 336-341. (Pubitemid 27184907)
404. Maneerat, W.; Laphookhieo, S.; Koysomboon, S.; Chantrapromma, K. Antimalarial, antimycobacterial and cytotoxic limonoids from Chisocheton siamensis. Phytomedicine, 2008, 15, 1130-1134.
405. Krief, S.; Martin, M.T.; Grellier, P.; Kasenene, J.; Sévenet, T. Novel antimalarial compounds isolated in a survey of self-medicative behavior of wild chimpanzees in Uganda. Antimicrob. Agents Chemother., 2004, 48, 3196-3199. (Pubitemid 38989204)
406. Barrera, C.A.C.; Barrera, E.D.C.; Falla, D.S.G.; Murcia, G.D. Suarez, L.E.C. seco-Limonoids and quinoline alkaloids from Raputia heptaphylla and their antileishmanial activity. Chem. Pharm. Bull., 2011, 59, 855-859.
407. Murata, T.; Miyase, T.; Muregi, F. W.; Naoshima-Ishibashi, Y.; Umehara, K.; Warashina, T.; Kanou, S.; Mkoji, G. M.; Terada, M.; Ishih, A. Antiplasmodial triterpenoids from Ekebergia capensis. J. Nat. Prod., 2008, 71, 167-174. (Pubitemid 351362972)
408. Saewan, N.; Sutherland, J.D.; Chantrapromma, K. Antimalarial tetranortriterpenoids from the seeds of Lansium domesticum Corr. Phytochemistry, 2006, 67, 2288-2293. (Pubitemid 44415910)
409. Khalid, S.A.; Friedrichsen, G.M.; Kharazmi, A.; Theander, T.; Christensen, S.B.; Olsen, C.E. Limonoids from Khaya senegalensis, Characterization of 2'',6-dihydroxy-fissinolide as a new limonoid. Phytochemistry, 1998, 49, 1769-1772.
410. Guo, Z.; Vangapandu, S.; Sindelar, R. W.; Walker, L. A.; Sindelar, R. D. Biologically active quassinoids and their chemistry: Potential leads for drug design. Curr. Med. Chem., 2005, 12, 173-190. (Pubitemid 40089832)
411. Almeida, M. M. B.; Arriaga, A. M. C.; Santos, A. K. L.; Lemos, T. L. G.; Braz-Filho, R.; Vieira, I. J. C. Ocorrência e atividade biológica de quassinóides da última década. Quim. Nova, 2007, 30, 935-951.
412. Murakami, N.; Sugimoto, M.; Kawanishi, M.; Tamura, S.; Kim, H.-S.; Begum, K.; Wataya, Y.; Kobayashi, M. New semisynthetic quassinoids with in vivo antimalarial activity. J. Med. Chem., 2003, 46, 638-641. (Pubitemid 36182765)
413. Fandeur, T.; Moretti, C.; Polonsky, J. In vitro and in vivo assessement of the antimalarial activity of sergeolide. Planta Med., 1985, 51, 20-23. (Pubitemid 15146407)
414. Cachet, N.; Hoakwie, F.; Bertani, S.; Bourdy, G.; Deharo, E.; Stien, D.; Houel, E.; Gornitzka, H.; Fillaux, J.; Chevalley, S.; Valentin, A.; Jullian, V. Antimalarial activity of simalikalactone E, a new quassinoid from Quassia amara L. (Simaroubaceae). Antimicrob. Agents Chemother., 2009, 53, 4393-4398.
415. Bertani, S.; Houel, E.; Stien, D.; Chevolot, L.; Jullian, V.; Garavito, G.; Bourdy, G.; Deharo, E. Simalikalactone D is responsible for the antimalarial properties of an amazonian traditional remedy made with Quassia amara L. (Simaroubaceae). J. Ethnopharmacol., 2006, 108, 155-157. (Pubitemid 44515139)
416. Moretti, C.; Deharo, E.; Sauvain, M.; Jardel, C.; David, P.; Gasquet, M. Antimalarial activity of cedronin. J. Ethnopharmacol., 1994, 43, 57-61. (Pubitemid 24186511)
417. Bray, D. H.; Boardman, P.; O'Neill, M. J.; Chan, K. L.; Phillipson, J. D.; Warhurst, D. C.; Suffness, M. Plants as a source of antimalarial drugs. 5. Activities of Ailanthus altissima stem constituents and of some related quassinoids. Phytother. Res., 1987, 1, 22-24.
418. Muhammad, I.; Bedir, E.; Khan, S. I.; Tekwani, B. L.; Khan, I. A.; Takamatsu, S.; Pelletier, J.; Walker, L. A. A new antimalarial quassinoid from Simaba orinocensis. J. Nat. Prod., 2004, 67, 772-777. (Pubitemid 38702731)